var title_f32_7_32880="Budesonide: Drug information";
var content_f32_7_32880=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Budesonide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/55/19317?source=see_link\">",
"       Budesonide (nasal): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/39/10873?source=see_link\">",
"       Budesonide (systemic therapy and oral inhalation): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9167 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-125.39.66.150-9E46D5F071-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32880=[""].join("\n");
var outline_f32_7_32880=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?18/55/19317?source=related_link\">",
"      Budesonide (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/39/10873?source=related_link\">",
"      Budesonide (systemic therapy and oral inhalation): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32881="Intussusception with small bowel obstruction";
var content_f32_7_32881=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intussusception",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of a child with intussusception shows small intestinal obstruction. Notable are a dilated small bowel and the absence of colonic gas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nancy Fitzgerald, MD and Taylor Chung, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32881=[""].join("\n");
var outline_f32_7_32881=null;
var title_f32_7_32882="Algorithm ectopic pregnancy";
var content_f32_7_32882=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 581px\">",
"   <div class=\"ttl\">",
"    Tests for suspected ectopic pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 561px; height: 668px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EP: ectopic pregnancy; IUP: intrauterine pregnancy;TVS: transvaginal ultrasound; hCG: human chorionic gonadotropin.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32882=[""].join("\n");
var outline_f32_7_32882=null;
var title_f32_7_32883="Granuloma annulare hand PI";
var content_f32_7_32883=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F87100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F87100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare on the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Granuloma annulare is a red, raised, circle-shaped rash that is not scaly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32883=[""].join("\n");
var outline_f32_7_32883=null;
var title_f32_7_32884="12 lead ECG atrial flutter";
var content_f32_7_32884=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75931&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75931&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    12 lead ECG of atrial flutter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 12 lead ECG of atrial flutter shows a regular rhythm with a narrow QRS complex. Flutter waves are present, best seen in leads 2, 3, and aVF (*). One flutter wave is obvious between the QRS complexes, while the second one is superimposed on the terminal portion of the QRS complex; hence there is 2:1 atrioventricular nodal block, which is the most common presentation for atrial flutter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission by Samuel Levy, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32884=[""].join("\n");
var outline_f32_7_32884=null;
var title_f32_7_32885="Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection";
var content_f32_7_32885=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Robert V Tauxe, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32885/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/7/32885/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yersinia species are gram-negative coccobacilli, which are facultative anaerobes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/1\">",
"     1",
"    </a>",
"    ]. Three species of Yersinia produce human illness: Y. pestis (the causative agent of human plague), Y. enterocolitica (the causative agent of yersiniosis), and Y. pseudotuberculosis. Y. enterocolitica and Y. pseudotuberculosis most commonly cause enterocolitis; Y. enterocolitica is the more common of the two species to cause disease.",
"   </p>",
"   <p>",
"    The treatment of Y. enterocolitica and Y. pseudotuberculosis infection will be reviewed here. The epidemiology, microbiology, pathogenesis, clinical manifestations, and diagnosis of these infections and issues related to plague are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31062?source=see_link\">",
"     \"Epidemiology of yersiniosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22373?source=see_link\">",
"     \"Microbiology and pathogenesis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41974?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/12/24774?source=see_link\">",
"     \"Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11512?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal treatment strategies for Yersinia spp. infections are unclear. Although treatment appears not to impact mild intestinal disease, fecal shedding decreases following antimicrobial treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/2\">",
"     2",
"    </a>",
"    ]. This by itself does not justify treatment, as person-to-person transmission is rare. However, antimicrobial treatment may be lifesaving in invasive infections.",
"   </p>",
"   <p>",
"    There has been one controlled trial of antimicrobial therapy for Y. enterocolitica infection and one for Y. pseudotuberculosis gastroenteritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Neither demonstrated a clinical benefit from treatment, though, in both treated groups, the pathogen was rapidly cleared from feces. In addition to these studies, treatment recommendations are based on susceptibility data and clinical case series.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     In vitro studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yersinia susceptibilities vary with the serotype, and therapeutic decisions should be guided by the susceptibility pattern of the clinical isolate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/1\">",
"     1",
"    </a>",
"    ]. The Y. enterocolitica serotype most commonly associated with illness (O:3) usually produces chromosomally-mediated beta-lactamases and thus is resistant to penicillin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , and most first generation cephalosporins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. Yersinia is also usually resistant to macrolides.",
"   </p>",
"   <p>",
"    Clinically significant strains are usually susceptible to other beta-lactam agents, aminoglycosides, tetracyclines,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and fluoroquinolones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/6\">",
"     6",
"    </a>",
"    ]. In one series, strains were uniformly susceptible to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    , imipenem,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/33/16919?source=see_link\">",
"     cefepime",
"    </a>",
"    , aminoglycosides, fluoroquinolones, and trimethoprim-sulfamethoxazole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Fluoroquinolone resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quinolone resistance, including resistance to nalidixic acid and reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , has been documented in Spain, due to mutations in DNA gyrase and an efflux pump, which may limit the effectiveness of these agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. As Y. enterocolitica rarely spreads from person to person, this resistance is more likely due to the use of antimicrobials in agriculture than in human medicine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Enterocolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are",
"    <strong>",
"     no",
"    </strong>",
"    controlled trials that indicate that antimicrobial treatment of acute, uncomplicated yersiniosis is beneficial. In a retrospective case series of Y. enterocolitica gastroenteritis from Norway (67 case-patients and 132 controls), treatment was not associated with a decreased duration of illness (18 versus 21 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/2\">",
"     2",
"    </a>",
"    ]. There also was no clinical benefit demonstrated in a small prospective, placebo-controlled trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    TMP and 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    SMX per day in two divided doses) in 34 Canadian children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/3\">",
"     3",
"    </a>",
"    ]. The initiation of therapy was significantly delayed in both studies (&gt;20 days after disease onset in Norway and 12 days in Canada), as the onset of yersiniosis is often insidious. It is unclear if earlier treatment would prove more beneficial. However, rapid microbiologic clearance of the organism was observed following treatment in both of these studies.",
"   </p>",
"   <p>",
"    There was no clinical benefit from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    treatment in a prospective placebo-controlled trial in 136 pediatric patients with Y. pseudotuberculosis infections in Japan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/4\">",
"     4",
"    </a>",
"    ]. Although there was no difference in clinical response between treatment and control groups, following five days of treatment, clearance of the organism was significantly greater in the ampicillin group (continued organism excretion 0 versus 90 percent, respectively). There is also",
"    <strong>",
"     no",
"    </strong>",
"    evidence that early antimicrobial therapy reduces the frequency or severity of chronic sequelae for either Y. enterocolitica or Y. pseudotuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most cases of Yersinia enterocolitis do not merit treatment and no clinical benefit of treatment has been documented. Bearing in mind the lack of clinical efficacy data, should treatment of an individual case be judged clinically necessary because of clinical severity or underlying condition of the patient (eg, immunocompromised patients), we suggest a fluoroquinolone such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (500 mg twice daily) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    for the pediatric patient (TMP 8",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day and SMX 40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two divided doses).",
"   </p>",
"   <p>",
"    We suggest",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    as alternatives to fluoroquinolones for complicated gastrointestinal infections or focal extraintestinal infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Septicemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are indicated for the treatment of complicated illness such as septicemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/12\">",
"     12",
"    </a>",
"    ]. Mortality associated with Yersinia bacteremia has decreased from 30 percent in the 1970s to less than 10 percent in the late 1980s, presumably as a result of improved therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a retrospective case series of 43 patients with Y. enterocolitica septicemia, third generation cephalosporins with or without other antibiotics were effective in 85 percent of cases; fluoroquinolones alone or in combination, cured all of 15 infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/14\">",
"     14",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     Ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    , first-generation cephalosporins, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    when used alone were not effective. The duration of therapy varied from two to six weeks, with a median of 22 days (intravenous followed by oral therapy).",
"   </p>",
"   <p>",
"    In patients with septicemia or severe disease, we recommend intravenous therapy with a third generation cephalosporin such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (2 g per day in adults",
"    <strong>",
"     or",
"    </strong>",
"    100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in one or two divided doses in children, to a maximum dose of 4 g per day) combined with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in one to three divided doses). An alternative antibiotic to replace ceftriaxone is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , if susceptible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no controlled trials examining the duration of antimicrobial therapy in Yersinia spp. infections. Treatment recommendations are based on clinical case series. We suggest that if enterocolitis is treated, patients should receive five days of oral antibiotics. We suggest that more severe extraintestinal infections, including septicemia, receive three weeks of therapy; the patient can be switched to oral agents, once clinically improved, to complete therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measures to prevent Yersinia infection include safe food processing and preparation and hand washing after exposure to pigs or pork products.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Food safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;The food industry plays a critical role in preventing yersiniosis. Reducing levels of contamination of raw pork products with Yersinia by improved hygiene at slaughter is important. Pasteurizing milk and maintaining high standards of sanitation in dairy plants prevents contamination of dairy products.",
"   </p>",
"   <p>",
"    The most common food vehicles implicated in Yersinia infection transmission are pork and pork products, particularly chitterlings. A common route of transmission is indirect, via the hands of the person handling the raw food to the formula bottle of the infant. Separating the two tasks of preparing raw meat foods and caring for an infant is an important prevention measure.",
"   </p>",
"   <p>",
"    Careful washing of hands, cutting boards and utensils with soap immediately after handling raw meats, as well as general measures to prevent cross contamination in the kitchen can help prevent transmission. Persons preparing pork should avoid eating raw or undercooked pork, even as part of adjusting spices while cooking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Animal exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Handwashing and the control of environmental cross-contamination are important measures to prevent zoonotic transmission of yersiniosis. Pigs are the natural reservoir for Yersinia spp. and thus, particular care after handling these animals is warranted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31062?source=see_link\">",
"     \"Epidemiology of yersiniosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Waterborne transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Waterborne transmission is prevented by routine municipal water treatment and disinfection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Transfusion-transmitted",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing units of packed red blood cells for the presence of bacterial endotoxin, and limiting the shelf-life of packed red cells may be helpful in preventing transfusion-associated sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32885/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10471?source=see_link\">",
"     \"Transfusion transmitted bacterial infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three species of Yersinia produce human illness: Yersinia pestis (the causative agent of human plague), Yersinia enterocolitica, and Yersinia pseudotuberculosis. Y. enterocolitica and Y. pseudotuberculosis most commonly cause enterocolitis (yersiniosis). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are",
"      <strong>",
"       no",
"      </strong>",
"      controlled trials that indicate that antimicrobial treatment of acute, uncomplicated yersiniosis is beneficial. We suggest",
"      <strong>",
"       NOT",
"      </strong>",
"      treating enterocolitis with antibiotics unless the patient has severe disease or has an underlying comorbid illness. (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Enterocolitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If enterocolitis requires treatment, we suggest treatment with a fluoroquinolone in adults (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      500 mg twice daily) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      in children (TMP 8",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day and SMX 40",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses). (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We typically treat with antibiotics for five days. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Enterocolitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend intravenous therapy for patients with septicemia or severe disease (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The preferred regimen is a third generation cephalosporin such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (2 g per day in adults",
"      <strong>",
"       or",
"      </strong>",
"      100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in one or two divided doses in children, to a maximum dose of 4 g per day) combined with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in one to three divided doses).",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"       Ciprofloxacin",
"      </a>",
"      (500 mg twice daily) can be used in place of ceftriaxone in adults if the isolate is susceptible. The typical duration of treatment is three weeks. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Septicemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures to prevent Yersinia infection include safe food processing and preparation and hand washing after exposure to pigs or pork products. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/1\">",
"      Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/2\">",
"      Ostroff SM, Kapperud G, Lassen J, et al. Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis 1992; 166:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/3\">",
"      Pai CH, Gillis F, Tuomanen E, Marks MI. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr 1984; 104:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/4\">",
"      Sato K, Ouchi K, Komazawa M. Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children. Pediatr Infect Dis J 1988; 7:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/5\">",
"      Pham JN, Bell SM, Hardy MJ, et al. Comparison of beta-lactamase production by Yersinia enterocolitica biotype 4, serotype O:3 isolated in eleven countries. Contrib Microbiol Immunol 1995; 13:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/6\">",
"      Preston M, Brown S, Borczyk A, et al. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990. Contrib Microbiol Immunol 1995; 13:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/7\">",
"      Stolk-Engelaar V, Meis J, Mulder J, et al. Activity of 24 antimicrobials against Yersinia enterocolitica. Contrib Microbiol Immunol 1995; 13:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/8\">",
"      Capilla S, Ruiz J, Go&ntilde;i P, et al. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. J Antimicrob Chemother 2004; 53:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/9\">",
"      Capilla S, Go&ntilde;i P, Rubio MC, et al. Epidemiological study of resistance to nalidixic acid and other antibiotics in clinical Yersinia enterocolitica O:3 isolates. J Clin Microbiol 2003; 41:4876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/10\">",
"      Fryd&eacute;n A, Bengtsson A, Foberg U, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990; 301:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/11\">",
"      Press N, Fyfe M, Bowie W, Kelly M. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib. Scand J Infect Dis 2001; 33:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/12\">",
"      Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med 1989; 321:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/13\">",
"      Jensen KT, Arpi M, Frederiksen W. Yersinia enterocolitica septicemia in Denmark 1972-1991: a report of 100 cases. Contrib Microbiol Immunol 1995; 13:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/14\">",
"      Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis 1993; 17:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/15\">",
"      Black RE, Slome S. Yersinia enterocolitica. Infect Dis Clin North Am 1988; 2:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32885/abstract/16\">",
"      Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3137 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-99A7E1262A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32885=[""].join("\n");
var outline_f32_7_32885=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      In vitro studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Fluoroquinolone resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Enterocolitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Septicemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Food safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Animal exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Waterborne transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Transfusion-transmitted",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41974?source=related_link\">",
"      Clinical manifestations and diagnosis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11512?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31062?source=related_link\">",
"      Epidemiology of yersiniosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/12/24774?source=related_link\">",
"      Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22373?source=related_link\">",
"      Microbiology and pathogenesis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10471?source=related_link\">",
"      Transfusion transmitted bacterial infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32886="Visual release hallucinations (Charles Bonnet syndrome)";
var content_f32_7_32886=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Visual release hallucinations (Charles Bonnet syndrome)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Victoria S Pelak, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32886/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/7/32886/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 17, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Charles Bonnet syndrome refers to symptoms of visual hallucinations that occur in patients with visual acuity loss or visual field loss. These are often called release hallucinations, reflecting the most widely accepted theory of their pathogenesis.",
"   </p>",
"   <p>",
"    Underlying conditions of vision loss associated with the Charles Bonnet syndrome affect the eye, optic nerve, or brain and include a diverse set of pathologies, such as macular degeneration and stroke. While often not functionally disabling, the hallucinations can be distressing to patients and negatively impact quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1\">",
"     1",
"    </a>",
"    ]. Published case reports suggest that the syndrome is not well recognized by clinicians and may often be misdiagnosed as psychosis or early dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiology, causes, clinical features, diagnosis, and treatment of the Charles Bonnet syndrome will be reviewed here. Other causes and the overall approach to visual hallucinations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/36/42569?source=see_link\">",
"     \"Approach to the patient with visual hallucinations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Charles Bonnet syndrome (CBS) may be more common than is generally appreciated. Visual hallucinations are often unreported by patients because they fear that they represent psychiatric disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. When this symptom is specifically solicited in older patients with impaired vision, 11 to 15 percent admit to having visual hallucinations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,5-11\">",
"     1,5-11",
"    </a>",
"    ]. In these surveys, most had failed to report these symptoms to their physician or to family members.",
"   </p>",
"   <p>",
"    Release hallucinations have been reported in all age groups, including children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/8,12\">",
"     8,12",
"    </a>",
"    ]. However, most patients with CBS are elderly; in large case series, the mean age is between 70 and 85 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4,8,13,14\">",
"     4,8,13,14",
"    </a>",
"    ]. This probably reflects the mean age at which the most common underlying conditions causing vision loss are seen. Some investigators, but not others, have found that advanced age is a risk factor for release hallucinations in their study population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/6,11,15\">",
"     6,11,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other conditions that are inconsistently found to be risk factors for CBS include cognitive impairment, cerebrovascular disease, cortical atrophy on brain imaging, and social deprivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/6,7,14-17\">",
"     6,7,14-17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with visual acuity loss or visual field loss from any cause, affecting any part of the visual pathway from the eye to the visual cortex, can develop visual hallucinations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4\">",
"     4",
"    </a>",
"    ]. Common underlying conditions include age-related macular degeneration, glaucoma, diabetic retinopathy, and cerebral infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,4,5,8,18\">",
"     1,4,5,8,18",
"    </a>",
"    ]. However, these hallucinations have been reported to occur in virtually every acquired disorder affecting the visual system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/8\">",
"     8",
"    </a>",
"    ]. CBS does not occur with congenital blindness.",
"   </p>",
"   <p>",
"    The most widely accepted theory is that the hallucinations occur when visual sensory deafferentation leads to disinhibition of visual cortical regions, which then fire spontaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/13,19-21\">",
"     13,19-21",
"    </a>",
"    ]. Similar hallucinations have been reported by individuals subjected to visual deprivation experiments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/8\">",
"     8",
"    </a>",
"    ]. Functional neuroimaging studies offer some support for this theory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/16,22,23\">",
"     16,22,23",
"    </a>",
"    ]. In four patients with CBS, functional magnetic resonance imaging revealed that active hallucinations were associated with spontaneous activity in the ventral occipital lobe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/22\">",
"     22",
"    </a>",
"    ]. The content of the hallucinations was associated with specific regional activation that correlated with the known specialized function of that area of the visual cortex.",
"   </p>",
"   <p>",
"    The neurobiology underlying visual hallucinations in CBS remains to be elucidated. In other settings, outside the visual system, deafferented neurons have been associated with a variety of biochemical, morphologic, and neurophysiologic changes that suggest a phenomenon of denervation hypersensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with chronic ocular disease, the diagnosis of ocular disease is generally established for at least one year before hallucinations emerge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ]. The likelihood of release hallucinations increases with lower visual acuity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4,15\">",
"     4,15",
"    </a>",
"    ]. While there is no clear threshold of visual acuity loss, the prevalence of hallucinations appears to increase with acuity worse than",
"    <span class=\"nowrap\">",
"     20/60",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. CBS is also more likely to occur with binocular versus monocular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, when release hallucinations occur in the setting of acute cerebral or optic nerve injury (eg, optic neuritis, stroke, surgery), they often occur concomitantly with the vision loss or after a latency of a few hours or days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/9,18,24-27\">",
"     9,18,24-27",
"    </a>",
"    ]. Latencies of more than several months have also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. A large visual field deficit is not required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Release hallucinations can be simple, nonformed images such as lines, light flashes, or geometric shapes, or they can be complex, formed images of people, animals, or scenes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/15,19,24,26\">",
"     15,19,24,26",
"    </a>",
"    ]. In a series of 59 patients with release hallucinations due to loss of vision from retinal or neurologic causes, simple hallucinations were more common than complex hallucinations (90 versus 37 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/15\">",
"     15",
"    </a>",
"    ]. The location of injury within the visual system did not determine the nature of the hallucinations. Others report a higher proportion of complex hallucinations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1\">",
"     1",
"    </a>",
"    ]. The content of the simple or complex hallucinations is variable, even for individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4,5,8\">",
"     4,5,8",
"    </a>",
"    ]. Although some patients perceive the same hallucination each time, they usually do not recur in a stereotyped fashion, a feature that distinguishes them from epileptic hallucinations.",
"   </p>",
"   <p>",
"    The images are usually colored and may be static, animated, or move en bloc across the visual field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/5,7,8\">",
"     5,7,8",
"    </a>",
"    ]. The images usually do not have emotional impact or personal meaning for the patient who almost always recognizes them as unreal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,4,5,15\">",
"     1,4,5,15",
"    </a>",
"    ]. There are no associated auditory or other sensory modality hallucinations. The location of the hallucinations typically corresponds to the underlying vision loss, and as a result, can be monocular or binocular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    restricted to one-half of the visual field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/15,18,24,26,32\">",
"     15,18,24,26,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hallucinations occur more often with the eyes open than closed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4\">",
"     4",
"    </a>",
"    ] and patients often describe seeing the hallucinations when they are looking at a white background such as a wall, ceiling, or a piece of paper. The hallucination will often disappear if the patient closes his eyes or looks away [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/24\">",
"     24",
"    </a>",
"    ]. In one study of 60 patients with CBS, most complex hallucinations occurred in the setting of sensory deprivation (eg, dim lighting, inactivity, being alone) and in the evening or nighttime [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The duration of the hallucination ranges from less than one minute to continuous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,4,5,7,33\">",
"     1,4,5,7,33",
"    </a>",
"    ]. Most patients report a duration of several minutes. The frequency is variable; the majority of patients experience hallucinations multiple times a day or week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1,5,18\">",
"     1,5,18",
"    </a>",
"    ]. Some patients experience only a few isolated episodes.",
"   </p>",
"   <p>",
"    Associated symptoms depend upon the underlying disorder producing the visual loss. As examples, strokes involving the visual pathways produce visual field loss and sometimes other neurologic deficits, while macular degeneration and diabetic retinopathy produce loss of visual acuity without neurologic deficits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/18\">",
"     18",
"    </a>",
"    ]. A syndrome of agitated delirium, visual hallucinations, and hemianopia can also be produced by lesions (usually stroke) affecting the medial aspect of the occipital lobe, the parahippocampal gyrus, and hippocampus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/18\">",
"     18",
"    </a>",
"    ]. This can be difficult to distinguish from acute toxic metabolic encephalopathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/36/42569?source=see_link&amp;anchor=H14#H14\">",
"     \"Approach to the patient with visual hallucinations\", section on 'Metabolic encephalopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other etiologies of visual hallucinations include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Migraine aura",
"     </li>",
"     <li>",
"      Epileptic seizures",
"     </li>",
"     <li>",
"      Neurodegenerative disease, especially dementia with Lewy bodies and Parkinson disease",
"     </li>",
"     <li>",
"      Drug or alcohol intoxication or withdrawal",
"     </li>",
"     <li>",
"      Metabolic encephalopathy, delirium",
"     </li>",
"     <li>",
"      Peduncular hallucinosis",
"     </li>",
"     <li>",
"      Narcolepsy",
"     </li>",
"     <li>",
"      Psychiatric disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Characteristics of the hallucinations and associated symptoms distinguish these causes from the release hallucinations of Charles Bonnet syndrome (",
"    <a class=\"graphic graphic_table graphicRef73106 \" href=\"mobipreview.htm?23/49/24349\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/36/42569?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to the patient with visual hallucinations\", section on 'Etiologies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with new onset visual hallucinations should have a complete neurologic evaluation screening for cognitive impairment, parkinsonism, and other neurologic deficits, and the medication list should be reviewed. In the absence of abnormalities, and in the setting of known ocular disease (eg, macular degeneration) further diagnostic evaluation may not be required.",
"   </p>",
"   <p>",
"    In comparison, in the absence of known eye disease, a complete ophthalmologic evaluation with visual field testing should be performed. Brain magnetic resonance imaging is indicated if there is a visual field deficit or other focal neurologic deficit and for patients in whom the cause remains obscure.",
"   </p>",
"   <p>",
"    Patients with atypical features for CBS should also be further evaluated (",
"    <a class=\"graphic graphic_table graphicRef73106 \" href=\"mobipreview.htm?23/49/24349\">",
"     table 1",
"    </a>",
"    ). As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with abnormal mental status should be evaluated for psychiatric disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      delirium with laboratory studies and toxicology screen.",
"     </li>",
"     <li>",
"      Associated auditory",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tactile hallucinations are not consistent with CBS and suggest possible psychiatric disease, peduncular hallucinosis, or narcoleptic hallucinations.",
"     </li>",
"     <li>",
"      Brief hallucinations that recur in a stereotyped fashion may indicate electroencephalography (EEG).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The general diagnostic approach to patients with visual hallucinations is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/36/42569?source=see_link\">",
"     \"Approach to the patient with visual hallucinations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Release hallucinations often resolve if the underlying vision deficit is corrected, as with cataract removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/8,34-36\">",
"     8,34-36",
"    </a>",
"    ]. Hallucinations can also remit in some patients with either static or progressive vision loss. This appears to occur more often for patients with acute cerebral injury (stroke, surgery), in whom hallucinations often last only several days to a few weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/9,18,25,26\">",
"     9,18,25,26",
"    </a>",
"    ]. However, such patients, as well as those with chronic ocular disease, can experience persistent hallucinations over several years.",
"   </p>",
"   <p>",
"    Treatment is individualized according to the degree the patient is disturbed by their symptoms. I have found that patients are often relieved to know that treatment is an option. This reassurance may be all that is required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients can also be taught to suppress the hallucinations. Rapid eye movements from one target to another, particularly away from the affected visual field, or eye closure may temporarily suppress the hallucination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/18,24\">",
"     18,24",
"    </a>",
"    ]. Increasing arousal and visual stimuli (eg, increased illumination), and reducing social deprivation are also reported to be useful for individual patients, but these techniques have not been systematically studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with continuous hallucinations or those with disturbing imagery may need specific treatment. While antipsychotic medications are sometimes cited as ineffective, others report benefit in individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/3,28,36,39,40\">",
"     3,28,36,39,40",
"    </a>",
"    ]. Newer (atypical) antipsychotic agents have fewer side effects than conventional agents, particularly in the elderly population. I have found that low doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    provide benefit without significant side effects. In my experience, cholinesterase inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    ) also can provide some relief with minimal side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/41\">",
"     41",
"    </a>",
"    ]. Antiepileptic drugs (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    ) are also helpful in anecdotal reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/30,35,42-46\">",
"     30,35,42-46",
"    </a>",
"    ]. Individual case reports also report benefit with cisapride and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32886/abstract/27,47\">",
"     27,47",
"    </a>",
"    ]. Even partial relief may provide benefit for patients who desire treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Charles Bonnet syndrome (CBS) refers to a phenomenon of visual hallucinations occurring in patients with acquired vision loss affecting the eye or visual tracts in the optic nerve, chiasm, or brain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risk factors for CBS include worse visual acuity and older age. Cognitive impairment and living conditions of sensory deprivation may also be risk factors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The hallucinations of CBS may be elementary (unformed flashes of light or geometric shapes) or complex (formed images often of animals, people or scenes). These typically last a few minutes and usually recur frequently, daily or weekly. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is made when these hallucinations occur in patients with vision loss in the absence of psychosis, delirium, or other causes. When there is no known history of vision loss, evaluation should include toxicology screen, ophthalmology consult, neurologic evaluation, visual field testing,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      brain imaging. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reassurance to patients is important and may be all that is required; however, treatment should be offered as well. Patients may be able to temporarily suppress hallucinations by closing their eyes or looking away. If hallucinations are troubling to patients, we suggest treatment trials with low doses of atypical antipsychotics, cholinesterase inhibitors, or antiepileptic drugs, all of which have anecdotal evidence of efficacy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Even partial alleviation of the hallucinations can bring relief to such patients. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prognosis and treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/1\">",
"      Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol 2001; 131:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/2\">",
"      Jacob A, Prasad S, Boggild M, Chandratre S. Charles Bonnet syndrome--elderly people and visual hallucinations. BMJ 2004; 328:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/3\">",
"      Siatkowski RM, Zimmer B, Rosenberg PR. The Charles Bonnet syndrome. Visual perceptive dysfunction in sensory deprivation. J Clin Neuroophthalmol 1990; 10:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/4\">",
"      Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/5\">",
"      Nesher R, Nesher G, Epstein E, Assia E. Charles Bonnet syndrome in glaucoma patients with low vision. J Glaucoma 2001; 10:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/6\">",
"      Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995; 166:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/7\">",
"      Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992; 149:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/8\">",
"      Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome. Surv Ophthalmol 2003; 48:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/9\">",
"      Freiman TM, Surges R, Vougioukas VI, et al. Complex visual hallucinations (Charles Bonnet syndrome) in visual field defects following cerebral surgery. Report of four cases. J Neurosurg 2004; 101:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/10\">",
"      Brown GC, Murphy RP. Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome. Arch Ophthalmol 1992; 110:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/11\">",
"      Abbott EJ, Connor GB, Artes PH, Abadi RV. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Invest Ophthalmol Vis Sci 2007; 48:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/12\">",
"      Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J AAPOS 1998; 2:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/13\">",
"      Schultz G, Melzack R. The Charles Bonnet syndrome: 'phantom visual images'. Perception 1991; 20:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/14\">",
"      Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis 1998; 186:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/15\">",
"      Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology 1990; 40:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/16\">",
"      Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci 2000; 54:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/17\">",
"      Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet Syndrome. Compr Psychiatry 1999; 40:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/18\">",
"      Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996; 47:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/19\">",
"      Cogan DG. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1973; 188:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/20\">",
"      Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002; 73:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/21\">",
"      Berrios GE, Brook P. The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly. Age Ageing 1982; 11:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/22\">",
"      Ffytche DH, Howard RJ, Brammer MJ, et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1998; 1:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/23\">",
"      Baier B, de Haan B, Mueller N, et al. Anatomical correlate of positive spontaneous visual phenomena: a voxelwise lesion study. Neurology 2010; 74:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/24\">",
"      K&ouml;lmel HW. Complex visual hallucinations in the hemianopic field. J Neurol Neurosurg Psychiatry 1985; 48:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/25\">",
"      Flint AC, Loh JP, Brust JC. Vivid visual hallucinations from occipital lobe infarction. Neurology 2005; 65:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/26\">",
"      Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain 1976; 99:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/27\">",
"      Lang UE, Stogowski D, Schulze D, et al. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007; 21:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/28\">",
"      Alao AO, Hanrahan B. Charles Bonnet syndrome: visual hallucination and multiple sclerosis. Int J Psychiatry Med 2003; 33:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/29\">",
"      Choi EJ, Lee JK, Kang JK, Lee SA. Complex visual hallucinations after occipital cortical resection in a patient with epilepsy due to cortical dysplasia. Arch Neurol 2005; 62:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/30\">",
"      Chen CS, Lin SF, Chong MY. Charles Bonnet syndrome and multiple sclerosis. Am J Psychiatry 2001; 158:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/31\">",
"      Komeima K, Kameyama T, Miyake Y. Charles Bonnet syndrome associated with a first attack of multiple sclerosis. Jpn J Ophthalmol 2005; 49:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/32\">",
"      Benson MT, Rennie IG. Formed hallucination in the hemianopic field. Postgrad Med J 1989; 65:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/33\">",
"      Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: a review. J Nerv Ment Dis 1997; 185:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/34\">",
"      Levine AM. Visual hallucinations and cataracts. Ophthalmic Surg 1980; 11:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/35\">",
"      Sonnenblick M, Nesher R, Rozenman Y, Nesher G. Charles Bonnet syndrome in temporal arteritis. J Rheumatol 1995; 22:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/36\">",
"      Holroyd S, Rabins PV. A three-year follow-up study of visual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996; 184:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/37\">",
"      Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom 2004; 87:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/38\">",
"      Plummer C, Kleinitz A, Vroomen P, Watts R. Of Roman chariots and goats in overcoats: the syndrome of Charles Bonnet. J Clin Neurosci 2007; 14:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/39\">",
"      Tueth MJ, Cheong JA, Samander J. The Charles Bonnet syndrome: a type of organic visual hallucinosis. J Geriatr Psychiatry Neurol 1995; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/40\">",
"      Coletti Moja M, Milano E, Gasverde S, et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci 2005; 26:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/41\">",
"      Ukai S, Yamamoto M, Tanaka M, Takeda M. Treatment of typical Charles Bonnet syndrome with donepezil. Int Clin Psychopharmacol 2004; 19:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/42\">",
"      Hori H, Terao T, Shiraishi Y, Nakamura J. Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 2000; 15:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/43\">",
"      Paulig M, Mentrup H. Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 2001; 70:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/44\">",
"      Chaudhuri A. Charles Bonnet syndrome: an example of cortical dissociation syndrome affecting vision. J Neurol Neurosurg Psychiatry 2000; 69:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/45\">",
"      G&ouml;rgens K, Liedtke M. [Charles Bonnet syndrome]. Psychiatr Prax 1998; 25:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/46\">",
"      Hosty G. Charles Bonnet syndrome: a description of two cases. Acta Psychiatr Scand 1990; 82:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32886/abstract/47\">",
"      Ranen NG, Pasternak RE, Rovner BW. Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry 1999; 7:264.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5250 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-F706DDF602-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32886=[""].join("\n");
var outline_f32_7_32886=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PROGNOSIS AND TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5250\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5250|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/49/24349\" title=\"table 1\">",
"      Disorders causing visual hallucinations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/36/42569?source=related_link\">",
"      Approach to the patient with visual hallucinations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32887="Ethics in the intensive care unit: Withholding and withdrawing life-support";
var content_f32_7_32887=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ethics in the intensive care unit: Withholding and withdrawing life-support",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     John A Kellum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     Douglas B White, MD, MAS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32887/contributors\">",
"     H Nancy Sokol, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/7/32887/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6536135\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who die in intensive care units (ICUs) do so when life-supporting measures are withheld or withdrawn (",
"    <a class=\"graphic graphic_figure graphicRef80424 \" href=\"mobipreview.htm?14/30/14830\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The decision to withhold or withdraw life-support is difficult for patients, families, and clinicians. It is influenced by many factors, including individuals&rsquo; values and treatment preferences, the patient&rsquo;s prognosis, and cultural, philosophical, and religious beliefs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to withholding or withdrawing life-supporting measures are reviewed here, with an emphasis on ethical considerations. Family meetings, the setting in which many decisions to withhold or withdraw life-support are made, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/40/12938?source=see_link\">",
"     \"Communication in the ICU: Holding a family meeting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2494950\">",
"    <span class=\"h1\">",
"     ESTABLISHING PATIENT VALUES AND GOALS OF CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important that clinicians make concerted efforts early in the patient&rsquo;s ICU stay to understand the patient&rsquo;s health-related values and medical goals (eg, restoring health, extending life, relieving pain and suffering,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    avoidance of prolonged dependence on life-support). Ideally clinicians would discuss treatment decisions with the patients; however, as many as 95 percent of critically ill patients are unable to make their own decisions because of the effects of the illness or medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/6\">",
"     6",
"    </a>",
"    ]. Patients may have advance directives that guide the clinician when patients are unable to participate in decision-making, but advance directives are often not available or unclear. In such cases, decisions are generally made by a surrogate decision-maker appointed by the patient or, in the absence of an appointed surrogate, by consensus with the family. Many states have an established legal hierarchy of surrogate decision-makers when a surrogate has not been previously appointed by the patient; typically, the hierarchy is the spouse, adult children, and then the parents of the patient. Some states allow physicians to implement decisions for patients who previously expressed their wishes to the physician, but no state allows physicians to make decisions for patients based upon the physician&rsquo;s view of the best interests of the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversations about goals of care are crucial so that patients receive care that is consistent with their values and are not subjected to unwanted burdensome treatments. Even when there is uncertainty about the patient&rsquo;s diagnosis or likely outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/8-11\">",
"     8-11",
"    </a>",
"    ], we believe it is important to engage surrogates in a conversation about the patient&rsquo;s values and preferences early in the ICU stay. Such conversations may be best initiated before there is consideration of withholding or withdrawing life support, in order to allow families time to begin to think about what are highly complex and emotionally difficult decisions. In our experience, it is often effective to meet with families within the first 48 hours after ICU admission to achieve four goals: to explain the medical situation, to elicit the patient&rsquo;s values and preferences, to emotionally support the family, and to begin to develop a trusting relationship [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/12\">",
"     12",
"    </a>",
"    ]. Once these goals are accomplished, there is a higher probability that clinicians and families will be able to effectively collaborate in the complex, emotionally charged decisions about goals of care. &nbsp;",
"   </p>",
"   <p>",
"    Despite the importance of establishing goals of care and understanding the patient&rsquo;s values and preferences, such discussions are frequently delayed or never occur. Clinicians may be reluctant to engage in these conversations in the setting of uncertainty about the patient&rsquo;s diagnosis or prognosis. &nbsp;Alternatively, they may fear that the surrogate or family will equate \"limiting the use of invasive treatments\" with \"limiting care\". Finally, some clinicians may avoid such conversations because they are often ethically and emotionally challenging.",
"   </p>",
"   <p>",
"    It is appropriate to consider withholding or withdrawing life-support when the available medical interventions are unlikely to achieve the patient&rsquo;s goals of care, or the duration or invasiveness of treatment required to achieve the patient&rsquo;s medical goals would be unacceptable to the patient. Once conversations about withholding or withdrawing life-support become appropriate and necessary, we recommend the phrase &ldquo;withdrawal of life-support&rdquo; rather than &ldquo;withdrawal of care&rdquo;. The former emphasizes that the patient will always receive care from the healthcare staff [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"     7",
"    </a>",
"    ]. It may be helpful to tell the surrogate or family, &ldquo;We will still care for your loved one, but we will change the focus of our care from cure to relief of pain and suffering.&rdquo;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6536626\">",
"    <span class=\"h1\">",
"     COMMON ETHICAL MISPERCEPTIONS ABOUT FOREGOING LIFE-SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions about withholding or withdrawing life support raise complex moral considerations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"     7",
"    </a>",
"    ]. Below we address four misperceptions that commonly arise about foregoing life support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17383129\">",
"    <span class=\"h2\">",
"     Is withdrawing life-support a form of patient abandonment?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some clinicians and surrogates may mistakenly believe that withdrawing life support in accord with the patient&rsquo;s values and preferences is a form of patient abandonment. Patient abandonment refers to a physician&rsquo;s act of withdrawing from an established physician-patient relationship without giving reasonable notice or providing a competent replacement. The misunderstanding arises from conflating the act of abandoning a treatment (such as mechanical ventilation) and the act of abandoning the patient (such as by abruptly discontinuing a therapeutic relationship). Withdrawing life support is not abandonment because the physician continues the therapeutic relationship with the patient and continues to provide medical treatments intended to palliate symptoms during the dying process. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17383143\">",
"    <span class=\"h2\">",
"     Does foregoing life sustaining treatment violate clinicians&rsquo; professional obligations to act beneficiently?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ethical guideline of beneficence requires clinicians to act to promote a patient&rsquo;s well being. It can be difficult for clinicians, who generally seek to extend life and forestall death, to acknowledge that in some circumstances the patient&rsquo;s interests will be best promoted by allowing them to die in a way that accords with their values and preferences, rather than live in ways they consider to be a &ldquo;state worse than death&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. These circumstances remind us that there are limits to what medicine can accomplish and limits to what patients are willing to accept in pursuit of extended life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17383150\">",
"    <span class=\"h2\">",
"     Is there an ethical difference between withholding and withdrawing life-sustaining treatment?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Withholding treatment is refraining from starting a therapy, whereas withdrawing treatment is stopping a therapy that has already been initiated. Clinicians tend to be more comfortable withholding life-sustaining measures than withdrawing them, probably because they perceive less causal responsibility for the patient&rsquo;s death. From the standpoint of United States (US) law and medical ethics, there is not an ethically meaningful distinction between withholding and withdrawing life-sustaining treatment. Both are permitted when doing so reflects an informed decision by the patient or the patient&rsquo;s surrogate. The US Supreme Court affirmed this logic in the Cruzan decision, articulating that it is legally and ethically permissible to withhold or withdraw any medical intervention, including nutrition and hydration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to consider what the consequences would be if withholding treatment was permitted, but withdrawing treatment was not. Most importantly, patients would not be permitted to request a time-limited trial of intensive care because, once started, life-support could not be withdrawn. Instead, they would be required to make an &lsquo;&lsquo;all-or-nothing&rsquo;&rsquo; decision in the early stage of an illness to either refuse life-support or to authorize indefinite use of life-support. This would be problematic because it would likely result in some patients who would prefer a time limited trial of intensive care to forego this desired opportunity for survival out of fear of being kept alive indefinitely attached to invasive life-support, a condition that some patients view as a &lsquo;&lsquo;state worse than death&rsquo;&rsquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17383165\">",
"    <span class=\"h2\">",
"     Is it unethical to administer sedatives and analgesics to dying patients if doing so may hasten death?",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is widespread agreement in the medical profession that it is ethically permissible to treat pain and other symptoms in a dying patient even if doing so might hasten the patient&rsquo;s death. This concern most commonly arises in ICUs in the context of the administration of analgesics and sedatives to treat distress during and after removal of mechanical ventilation. In this circumstance, it is possible that the respiratory depressant effect of the medications may cause more rapid death than would occur without their administration. &nbsp;",
"   </p>",
"   <p>",
"    There are several potential justifications for permitting aggressive symptom control in dying patients even if a hastened death may result [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/16\">",
"     16",
"    </a>",
"    ]. The most common justification is the doctrine of double effect (DDE). This doctrine distinguishes effects that are intended from those that are foreseeable but unintended. Applying the DDE to the administration of narcotics during withdrawal of life support, the DDE holds that it is ethically permissible to administer narcotics if death (the bad outcome) is not intended and instead that the intention is to control the patient&rsquo;s discomfort (the good outcome). The DDE, therefore, depends upon an assessment of a clinician&rsquo;s intentions, which can be difficult to ascertain and may involve multiple intentions simultaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/17\">",
"     17",
"    </a>",
"    ]. Several other conditions must be met to satisfy the DDE:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The bad effect cannot be the means to the good effect. As an example, although giving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/57/34711?source=see_link\">",
"       potassium chloride",
"      </a>",
"      to a dying patient would likely result in cessation of patient discomfort, it is ruled out under the DDE because it produces the good effect through the bad effect; that is, the bad effect (death) is necessary for the good effect (pain relief) to be realized. This differs from the use of sedatives and analgesics since their usual purpose is to relieve suffering without causing the death of the patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The intended (good) effect must be proportionate to the foreseeable but unintended (bad) outcome. In other words, the intended effect should be sufficiently important to justify the possibility of a bad outcome. As an example, in a patient very close to death from end-stage illness, the relief of distressing symptoms is commonly viewed to be sufficiently important to permit the possibility of a hastened death that may result from aggressive symptom control with sedatives and analgesics. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Legal views in the US generally accord with the DDE. For example, in the legal case of Vacco versus Quill, former Chief Justice William Rehnquist wrote: &lsquo;&lsquo;It is widely recognized that the provision of pain medication is ethically and professionally acceptable even when the treatment may hasten the patient&rsquo;s death if the medication is intended to alleviate pain and severe discomfort, not to cause death&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1264333\">",
"    <span class=\"h1\">",
"     CAUSES OF CONFLICT AND RESOLUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding withholding or withdrawing life-sustaining therapy frequently cause conflicts between clinicians and surrogates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. These conflicts can arise from multiple causes, which can be generally categorized as arising from either inadequate communication or value conflicts. The role of strong emotions and deeply held religious or secular beliefs about the end of life should not be underestimated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14284879\">",
"    <span class=\"h2\">",
"     Inadequate communication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Communication is consistently identified by the family members of ICU patients as the most important and least accomplished aspect of quality of care according to numerous studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/20,22-25\">",
"     20,22-25",
"    </a>",
"    ]. Clinicians tend to underestimate the information needs of patients, surrogates, and families, and frequently lack the skills to communicate complex medical information [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/26\">",
"     26",
"    </a>",
"    ]. It has been estimated that half of family members fail to understand even basic information about the patient's diagnosis, prognosis, or treatment; as a result, anxiety and confusion is widespread among family members [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Inadequate emotional support of a family may also contribute to conflict. Numerous studies have shown that acting as a surrogate is frequently associated with a long-lasting negative emotional burden, including stress, guilt, and doubt about the decisions that were made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regardless of whether the cause of the conflict is poor communication or emotionally overwhelmed surrogates, empirical studies suggest that clinicians and surrogates can reach consensus through ongoing and honest communication and negotiation. This was illustrated by an observational study in a medical ICU that found that, through the course of serial family meetings, clinicians and families reached consensus about the appropriate plan of care in 96 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Attending to strong emotions and allowing families sufficient time to come to terms with the patient&rsquo;s prognosis may be important steps to overcome conflict. Better use of social workers, chaplains, and other family support services may be particularly helpful to surrogates who are emotionally overwhelmed. Soliciting the assistance of the patient&rsquo;s primary care physician also can help facilitate conflict resolution, particularly if there is not an established relationship between the patient and the team of ICU clinicians.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14284986\">",
"    <span class=\"h2\">",
"     Value conflicts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although inadequate communication",
"    <strong>",
"    </strong>",
"    is the most common cause of conflict, some conflicts arise due to genuine value conflicts about the appropriate plan of treatment. Such conflicts can arise between members of the clinical team, between family members, or between the family and the clinical team. Examples of value conflicts include situations in which surrogates request treatments that the physician judges to be contrary to the patient&rsquo;s expressed wishes or, in the absence of clear information about the patient&rsquo;s preferences, different opinions about what goals of care are consistent with the patient&rsquo;s best interests. A trial randomly assigned 551 critically ill patients in whom a value laden treatment conflict arose to receive either an ethics consultation or to continue usual care alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/32\">",
"     32",
"    </a>",
"    ]. The group that received the ethics consultation had a shorter ICU length of stay and hospital length of stay among patients who died. Eighty seven percent of the participants viewed the ethics consults as helpful.",
"   </p>",
"   <p>",
"    Ongoing and honest discussions between the clinician and the surrogate are the most likely ways to resolve a value laden disagreement. Ethics or palliative care consultants may be particularly beneficial in this setting. Social workers, chaplains, and other family support services can also be helpful, as may the patient&rsquo;s primary care physician especially if there is not an established relationship between the patient and the team of ICU clinicians. Rarely, clinician-family conflict about whether to forego life sustaining treatment will be intractable. Strategies to fairly resolve such conflicts are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24934?source=see_link&amp;anchor=H5034262#H5034262\">",
"     \"Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies\", section on 'Recommended approach to dispute resolution'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2495592\">",
"    <span class=\"h1\">",
"     PRACTICAL ASPECTS OF WITHDRAWING LIFE-SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the decision has been made to withdraw life-sustaining measures, the surrogate and family should be prepared for the dying process. Anticipated changes in the respiratory pattern should be described as a normal part of the dying process. Clinicians should offer families the opportunity to meet with clergy or a social worker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"     7",
"    </a>",
"    ]. Families should also be offered the opportunity to spend time with their loved one prior to withdrawal of life support, in order to say good bye and to facilitate a life review [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/40/12938?source=see_link&amp;anchor=H18#H18\">",
"     \"Communication in the ICU: Holding a family meeting\", section on 'End-of-life issues'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following recommendations explain how to humanely withdraw life-sustaining treatment in patients receiving mechanical ventilation. However, there are several caveats. First, this approach is intended for patients for whom the goals of care are focused on palliation of symptoms, rather than life prolongation, and who are expected to die following the withdrawal of life support. Second, the strategy to manage terminal extubation must always be individualized to reflect the clinical situation as well as the values and preferences of the patient. As an example, some patients may place a very high priority on maintaining as much mental clarity as possible through the dying process, even if this involves a greater risk of suffering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/34\">",
"     34",
"    </a>",
"    ]. Such preferences should result in a very different strategy to manage respiratory distress compared with a patient who highly values symptom control and does not desire to be conscious at the end of life.",
"   </p>",
"   <p>",
"    Excellent order sets have been developed and published to facilitate consistent approaches to withdrawing mechanical ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/35\">",
"     35",
"    </a>",
"    ]. The main considerations are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ensure that analgesics and sedatives are at the bedside to treat patient discomfort &ndash; Patient distress can occur rapidly with cessation of ventilator support; therefore, it is important to ensure that appropriate medications are readily available at the bedside. We recommend preparing infusions of narcotics and sedatives, as well as bolus doses of rapidly acting agents (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      ), to manage acute symptoms.",
"      <strong>",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Discontinue interventions that do not provide comfort &ndash; Routine interventions that provide no comfort to the patient (eg, blood draws and radiographs) should be discontinued. All therapies should be reevaluated and those that do not contribute to patient comfort should be discontinued, including antibiotics, vasopressors, intravenous fluids, nutrition, and dialysis. A do-not-resuscitate (DNR) order should be documented. Cessation of monitoring should be considered, since electronic monitoring adds little to the bedside clinicians&rsquo; assessment of distress in dying patients, does not provide comfort to the family, and may cause family members to pay more attention to the monitors and alarms than the patient. Neuromuscular blocking agents should be discontinued and neuromuscular function should be allowed to return prior to the withdrawal of life support. One reason for discontinuing neuromuscular blocking agents is that the presence of neuromuscular blockade masks signs of discomfort and therefore creates a risk that patients will die with inadequately treated symptoms. Expert consultation (eg, palliative care or ethics consultants) should be sought in the very rare cases in which it is felt that waiting for the return of neuromuscular function would be unduly burdensome to the patient or would cause intractable distress from neuromuscular abnormalities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Incrementally reduce the ventilator support and treat the patient&rsquo;s symptoms &ndash; It is usually possible to decrease the ventilator support (ie, gradually decreasing the fraction of inspired oxygen and the amount of positive pressure ventilation) over a period of 10 to 30 minutes in a way that allows the patient to comfortably transition to spontaneous breathing on room air through the endotracheal tube. A central feature of this process is that each incremental decrease in ventilator support should be accompanied by a careful assessment and treatment of respiratory distress. Intravenous analgesics (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      ) should be administered in doses judged to be appropriate to treat the symptoms. It is important to note that the required analgesic doses will vary widely from patient to patient. Patients who have been on high doses of narcotics in the ICU will likely require higher doses to control symptoms relative to patients who have not been receiving analgesics. There is no upper limit on acceptable doses, as long as the dose is selected with the goal to be proportional to the patient&rsquo;s symptoms and is titrated to the patient&rsquo;s symptoms. Orders that call for a steady increase in the dose of a morphine infusion, without reference to whether the patient is experiencing pain or suffering, lacks this essential element of titration. Such orders are ethically problematic because they may suggest that the primary intention of the physician is to cause the patient&rsquo;s death, rather than to treat the patient&rsquo;s symptoms. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Assess the need for anticipatory dosing of narcotics and sedatives &ndash; In some situations, the withdrawal of mechanical ventilation from a patient will result in a sudden increase in dyspnea, even if the patient has been incrementally weaned from ventilator support and there has been a gradual titration of analgesics and sedatives. The concept of &ldquo;anticipatory dosing&rdquo; may guide clinicians when such severe distress is anticipated",
"      <em>",
"       .",
"      </em>",
"      Recommendations from the Society of Critical Care Medicine address this point clearly: &ldquo;The concept of &lsquo;anticipatory dosing&rsquo; (as opposed to reactive dosing) also should guide clinicians in the use of sedation and analgesia at the end of life. . . At the time of ventilator withdrawal, the clinician can anticipate that there will be a sudden increase in dyspnea. It is not sufficient simply to respond to this distress with titrated doses of an opioid (reactive dosing). Rather, clinicians should anticipate this sudden event and provide adequate medication beforehand (anticipatory dosing)&rdquo; [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32887/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extubate the patient &ndash; Although it is acceptable to leave the endotracheal tube in place, we generally favor extubating the patient in order to avoid patient discomfort from an endotracheal tube, to free the patient from unnecessary lines and tubes prior to death, and to facilitate a more natural appearance during the dying process. Occasionally, extubation will cause an increase in respiratory distress from upper airway obstruction. We generally manage this with rapid titration of short-acting intravenous narcotics. In rare circumstances, it may be necessary to temporarily apply a jaw thrust maneuver until the analgesics adequately take effect. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Continue to carefully assess and treat symptoms &ndash; After extubation, patients should generally remain in a clinical setting that allows for frequent patient monitoring and treatment of symptoms until it is clear that their symptoms are well controlled and not rapidly changing. Actively dying patients with difficult to treat symptoms may benefit from ongoing care in the intensive care unit to ensure a comfortable death. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bereavement support for families &ndash; Many hospitals have palliative care teams that can provide assistance at insuring patient comfort. Symptom management during end-of-life care is described separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/7/35962?source=see_link\">",
"       \"Overview of managing common non-pain symptoms in palliative care\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2494901\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients who die in the intensive care unit (ICU) do so after life-supporting measures are withheld or withdrawn. (See",
"      <a class=\"local\" href=\"#H6536135\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is appropriate to consider withholding or withdrawing life support when the available medical interventions are either unlikely to achieve the goals of care or become unacceptable to the patient. Thus, it is important that the goals of medical care (eg, restoring health, extending life, or relieving pain and suffering) and the patient&rsquo;s values and preferences be established early. (See",
"      <a class=\"local\" href=\"#H2494950\">",
"       'Establishing patient values and goals of care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many patients are unable to participate in discussions about the goals of their medical care. In such cases, decisions are generally made by a surrogate decision-maker appointed by the patient or, in the absence of a surrogate, by consensus with the family. Many states have an established legal hierarchy of surrogate decision-makers when a surrogate has not been previously appointed by the patient. (See",
"      <a class=\"local\" href=\"#H2494950\">",
"       'Establishing patient values and goals of care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decisions regarding withholding or withdrawing life-sustaining therapy frequently cause conflicts between the clinical team and family, as well as within the family and clinical team. Regardless of the cause of the conflict, ongoing and honest discussion between the clinicians and the surrogate decision-maker or family is an important aspect of conflict resolution. (See",
"      <a class=\"local\" href=\"#H1264333\">",
"       'Causes of conflict and resolution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the decision has been made to withhold or withdraw life-sustaining measures, the surrogate and family should be prepared for the dying process. It should be reiterated and emphasized that the patient will receive attentive and compassionate care aimed at the relief of pain and suffering. Cessation of monitoring should be considered, routine interventions that provide no comfort to the patient (eg, blood draws, radiographs) should be discontinued, and all therapies should be reevaluated. Those therapies that do not contribute to patient comfort should be discontinued. Patients who are mechanically ventilated may be either extubated or left intubated and terminally weaned. (See",
"      <a class=\"local\" href=\"#H2495592\">",
"       'Practical aspects of withdrawing life-support'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/1\">",
"      Fisher M. Ethical issues in the intensive care unit. Curr Opin Crit Care 2004; 10:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/2\">",
"      Manara AR, Pittman JA, Braddon FE. Reasons for withdrawing treatment in patients receiving intensive care. Anaesthesia 1998; 53:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/3\">",
"      Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med 1998; 158:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/4\">",
"      Sprung CL, Cohen SL, Sjokvist P, et al. End-of-life practices in European intensive care units: the Ethicus Study. JAMA 2003; 290:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/5\">",
"      Curtis JR, Vincent JL. Ethics and end-of-life care for adults in the intensive care unit. Lancet 2010; 376:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/6\">",
"      Luce JM. End-of-life decision making in the intensive care unit. Am J Respir Crit Care Med 2010; 182:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/7\">",
"      Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College [corrected] of Critical Care Medicine. Crit Care Med 2008; 36:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/8\">",
"      Thi&eacute;ry G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23:4406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/9\">",
"      Predicting outcome in ICU patients. 2nd European Consensus Conference in Intensive Care Medicine. Intensive Care Med 1994; 20:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/10\">",
"      Atkinson S, Bihari D, Smithies M, et al. Identification of futility in intensive care. Lancet 1994; 344:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/11\">",
"      Halevy A, Neal RC, Brody BA. The low frequency of futility in an adult intensive care unit setting. Arch Intern Med 1996; 156:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/12\">",
"      White DB, Braddock CH 3rd, Bereknyei S, Curtis JR. Toward shared decision making at the end of life in intensive care units: opportunities for improvement. Arch Intern Med 2007; 167:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/13\">",
"      Pearlman RA, Cain KC, Patrick DL, et al. Insights pertaining to patient assessments of states worse than death. J Clin Ethics 1993; 4:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/14\">",
"      Patrick DL, Starks HE, Cain KC, et al. Measuring preferences for health states worse than death. Med Decis Making 1994; 14:9.",
"     </a>",
"    </li>",
"    <li>",
"     Cruzan v Missouri Department of Health, 497 US 261, 110 SCt 2841 (1990).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/16\">",
"      Truog RD, Brock DW, White DB. Should patients receive general anesthesia prior to extubation at the end of life?. Crit Care Med 2012; 40:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/17\">",
"      Wilson WC, Smedira NG, Fink C, et al. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. JAMA 1992; 267:949.",
"     </a>",
"    </li>",
"    <li>",
"     Vacco v Quill, 117 SCt 2293 (1997).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/19\">",
"      Breen CM, Abernethy AP, Abbott KH, Tulsky JA. Conflict associated with decisions to limit life-sustaining treatment in intensive care units. J Gen Intern Med 2001; 16:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/20\">",
"      Abbott KH, Sago JG, Breen CM, et al. Families looking back: one year after discussion of withdrawal or withholding of life-sustaining support. Crit Care Med 2001; 29:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/21\">",
"      Azoulay E, Timsit JF, Sprung CL, et al. Prevalence and factors of intensive care unit conflicts: the conflicus study. Am J Respir Crit Care Med 2009; 180:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/22\">",
"      McDonagh JR, Elliott TB, Engelberg RA, et al. Family satisfaction with family conferences about end-of-life care in the intensive care unit: increased proportion of family speech is associated with increased satisfaction. Crit Care Med 2004; 32:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/23\">",
"      Arnold RM, Kellum J. Moral justifications for surrogate decision making in the intensive care unit: implications and limitations. Crit Care Med 2003; 31:S347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/24\">",
"      Levy MM. End-of-life care in the intensive care unit: can we do better? Crit Care Med 2001; 29:N56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/25\">",
"      Hanson LC, Danis M, Garrett J. What is wrong with end-of-life care? Opinions of bereaved family members. J Am Geriatr Soc 1997; 45:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/26\">",
"      Kutner JS, Steiner JF, Corbett KK, et al. Information needs in terminal illness. Soc Sci Med 1999; 48:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/27\">",
"      Azoulay E, Chevret S, Leleu G, et al. Half the families of intensive care unit patients experience inadequate communication with physicians. Crit Care Med 2000; 28:3044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/28\">",
"      Pochard F, Azoulay E, Chevret S, et al. Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 2001; 29:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/29\">",
"      Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions for others. Ann Intern Med 2011; 154:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/30\">",
"      Prendergast TJ. Resolving conflicts surrounding end-of-life care. New Horiz 1997; 5:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/31\">",
"      Garros D, Rosychuk RJ, Cox PN. Circumstances surrounding end of life in a pediatric intensive care unit. Pediatrics 2003; 112:e371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/32\">",
"      Schneiderman LJ, Gilmer T, Teetzel HD, et al. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 2003; 290:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/33\">",
"      Chochinov HM. Dying, dignity, and new horizons in palliative end-of-life care. CA Cancer J Clin 2006; 56:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/34\">",
"      B&uuml;low HH, Sprung CL, Reinhart K, et al. The world's major religions' points of view on end-of-life decisions in the intensive care unit. Intensive Care Med 2008; 34:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/35\">",
"      Treece PD, Engelberg RA, Crowley L, et al. Evaluation of a standardized order form for the withdrawal of life support in the intensive care unit. Crit Care Med 2004; 32:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32887/abstract/36\">",
"      Truog RD, Cist AF, Brackett SE, et al. Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med 2001; 29:2332.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16295 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-25B04CEC5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32887=[""].join("\n");
var outline_f32_7_32887=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2494901\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6536135\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2494950\">",
"      ESTABLISHING PATIENT VALUES AND GOALS OF CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6536626\">",
"      COMMON ETHICAL MISPERCEPTIONS ABOUT FOREGOING LIFE-SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17383129\">",
"      Is withdrawing life-support a form of patient abandonment?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17383143\">",
"      Does foregoing life sustaining treatment violate clinicians&rsquo; professional obligations to act beneficiently?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17383150\">",
"      Is there an ethical difference between withholding and withdrawing life-sustaining treatment?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17383165\">",
"      Is it unethical to administer sedatives and analgesics to dying patients if doing so may hasten death?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1264333\">",
"      CAUSES OF CONFLICT AND RESOLUTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14284879\">",
"      Inadequate communication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14284986\">",
"      Value conflicts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2495592\">",
"      PRACTICAL ASPECTS OF WITHDRAWING LIFE-SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2494901\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PALC/16295\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PALC/16295|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/30/14830\" title=\"figure 1\">",
"      End of life care in ICU",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/40/12938?source=related_link\">",
"      Communication in the ICU: Holding a family meeting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24934?source=related_link\">",
"      Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/7/35962?source=related_link\">",
"      Overview of managing common non-pain symptoms in palliative care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32888="Depersonalization disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis";
var content_f32_7_32888=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Depersonalization disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     Daphne Simeon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     David Spiegel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32888/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/7/32888/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H10290103\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depersonalization is a persistent or recurrent feeling of detachment or estrangement from one&rsquo;s self [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/1\">",
"     1",
"    </a>",
"    ]. An individual experiencing depersonalization may report feeling like an automaton or as if in a dream or watching himself or herself in a movie. Depersonalized individuals may report the sense of being an outside observer of their mental processes or their body. They often report feeling a loss of control over their thoughts, perceptions, and actions.",
"   </p>",
"   <p>",
"    Depersonalization disorder (DPD) is characterized by the persistence or recurrence of depersonalization, which causes clinically significant distress or impairment, in the presence of intact reality testing. Individuals with DPD frequently experience derealization, ie, a subjective sense of detachment or unreality regarding the world around them. DPD has a prevalence of approximately two percent and is associated with significant morbidity, but often goes undetected or misdiagnosed, leading to delays in treatment.",
"   </p>",
"   <p>",
"    This topic discusses the epidemiology, pathogenesis, clinical manifestations, course, and diagnosis of DPD. Treatment of DPD is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/55/21367?source=see_link\">",
"     \"Treatment of depersonalization disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289528\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2022939\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient experiences of depersonalization and derealization are very common in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/2\">",
"     2",
"    </a>",
"    ]. In a non-urban US sample, the one-year prevalence of depersonalization symptoms was approximately 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/3\">",
"     3",
"    </a>",
"    ]. Approximately half of college students in another US study reported experiencing an episode of depersonalization in the past year. Adolescents and young adults appear to be at the highest risk for reporting such symptoms, possibly because of a still fluid and developmentally unstable sense of self. &nbsp;",
"   </p>",
"   <p>",
"    Depersonalization disorder (DPD) is less prevalent than transient depersonalization symptoms, as its essence is chronicity, associated morbidity, and primary presence (ie, not due to another condition). Studies from several countries including the US, Canada, United Kingdom, Turkey, and Germany have shown a lifetime prevalence for DPD in the range of 0.8 percent to 2.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], comparable to that of other DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text revision) disorders such as schizophrenia, bipolar disorder, and OCD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2022925\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;DPD has been found to be equally common in men and women in clinical samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Risk factors for depersonalization include acute and chronic trauma or severe stress, co-morbid psychiatric conditions including anxiety or depressive disorders, substance abuse, as well as hypnotizability and sensory deprivation. (See",
"    <a class=\"local\" href=\"#H820260\">",
"     'Role of trauma'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H253900\">",
"     'Organic precursors'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H2022362\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Chronic depersonalization has been reported in as many as one-third to one-half of individuals experiencing chronic traumatic or highly stressful situations. Examples of these situations include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Childhood abuse or neglect",
"     </li>",
"     <li>",
"      Unexpected death of a loved one",
"     </li>",
"     <li>",
"      Growing up with a seriously mentally ill parent",
"     </li>",
"     <li>",
"      Sexual orientation conflicts in adolescence",
"     </li>",
"     <li>",
"      Serious family or work stressors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, a clear proximal traumatic antecedent cannot be identified in about half of cases of chronic depersonalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H820260\">",
"     'Role of trauma'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2022763\">",
"    <span class=\"h2\">",
"     Comorbid conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on relatively small studies, primary DPD appears to have high rates of comorbidity with other psychiatric disorders. As an example, in a study of 117 US adults with DPD, the lifetime prevalence of comorbid disorders was as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unipolar depression, 73 percent",
"     </li>",
"     <li>",
"      Any anxiety disorder, 64 percent",
"     </li>",
"     <li>",
"      Obsessive-compulsive disorder, 21 percent",
"     </li>",
"     <li>",
"      Avoidant personality disorder, 23 percent",
"     </li>",
"     <li>",
"      Borderline personality disorder, 21 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289535\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the pathogenesis of depersonalization disorder (DPD) has not been established, it is generally assumed that the syndrome becomes manifest in individuals who have inherent diatheses combined with psychological",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemical stressors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H820260\">",
"    <span class=\"h2\">",
"     Role of trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depersonalization is one of the quintessential responses to acute trauma (such as a motor vehicle accident), speculated to be hardwired into the brain so that a sense of distance and detachment from the traumatic event can facilitate surviving and negotiating the event without experiencing overwhelming, disorganizing emotion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. High rates of chronic depersonalization have also been found among persons experiencing chronic traumatic or highly stressful situations such verbal or emotional abuse or neglect during childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Other situations include growing up frightened by a parent with severe mental illness, traumatically struggling with sexual orientation, or experiencing the unexpected death or suicide of a family member or close friend. Sexual abuse and severe physical abuse are less common antecedents of depersonalization disorder (DPD). Numerous other severe life stressors (interpersonal, financial, or occupational) have been associated with onset or exacerbation of DPD. Examples include a very difficult divorce, academic failure, or job loss.(See",
"    <a class=\"local\" href=\"#H2022925\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Chronic depersonalization has also been reported to begin during severe or prolonged episodes of a mood or anxiety disorder, which may destabilize the sense of usual expected self [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The traumas reported by DPD patients are generally less severe than those typically reported by patients with other dissociative disorders, such as dissociative identity disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/56/11146?source=see_link\">",
"     \"Dissociative identity disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H253900\">",
"    <span class=\"h2\">",
"     Organic precursors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common organic risk factors for depersonalization include seizures and mild to moderate head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/12\">",
"     12",
"    </a>",
"    ]. Substance abuse has been known to precipitate chronic depersonalization in some people [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2022362\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These individuals can be conceptualized as having a neurobiological or genetic vulnerability to the onset of chronic depersonalization after drug use. A large survey study has shown that the characteristics and course of the condition do not differ between drug-induced and non-drug-induced cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H409471\">",
"    <span class=\"h2\">",
"     Neurobiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although relevant research data are scant, several neurotransmitter systems, brain areas, and functional circuits have been associated with depersonalization symptoms with some consistency and are summarized below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/14\">",
"     14",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NMDA (N-methyl-D-aspartate) system &mdash; NMDA receptors are widely distributed in the cortex, hippocampus, and amygdala, and mediate associative processes. &nbsp;The NMDA antagonist",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      induces a profound dissociative state in healthy subjects that has been likened to, but is thought to be partly distinct from in the implicated brain pathways, the psychotomimetic effects of ketamine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. Pretreatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      in healthy volunteers reduces the dissociative impact of ketamine administration, possibly via NMDA receptor blockade [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Endogenous cannabinoid system &mdash; Cannabis has been experimentally shown to induce depersonalization in healthy volunteers, with a pronounced component of temporal disintegration, and particular brain regions have been implicated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/17\">",
"       17",
"      </a>",
"      ]. Cannabinoids block NMDA receptors at sites distinct from other noncompetitive NMDA antagonists [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/18\">",
"       18",
"      </a>",
"      ] and therefore their dissociative effect may be partly mediated via NMDA antagonism.",
"     </li>",
"     <li>",
"      Kappa opioid agonists &mdash; The illicit drug salvia, which acts as a selective kappa opioid agonist, has been found to precipitate chronic depersonalization [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/13\">",
"       13",
"      </a>",
"      ]. In an experimental study of healthy volunteers, placebo-controlled pharmacological challenge with the kappa opioid agonist enadoline induced a &ldquo;clean&rdquo; depersonalization-like syndrome with perceptual disturbances and a sense of detachment in the absence of prominent mood, anxiety, or psychotomimetic effects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/19\">",
"       19",
"      </a>",
"      ]. Although selective kappa opioid antagonists are still in Phase II trials, non-selective antagonists such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      , and nalmefene, which have varying affinity for the kappa receptor, have been reported to diminish dissociative symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/55/21367?source=see_link&amp;anchor=H2849923#H2849923\">",
"       \"Treatment of depersonalization disorder\", section on 'Naltrexone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serotonin agonists &mdash; Hallucinogens act as agonists at serotonin 5HT2A and especially 5HT2C receptors, and experimental challenge studies with the partial 5HT2A and C agonist m-CPP have demonstrated the induction of depersonalization in a mixed group of social phobia, borderline personality disorder, and obsessive-compulsive disorder participants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/20\">",
"       20",
"      </a>",
"      ], the induction of flashbacks and dissociative symptoms in a subgroup of PTSD patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/21\">",
"       21",
"      </a>",
"      ], and the induction of dissociation in healthy volunteers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is some evidence for autonomic hypo-reactivity in DPD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/23\">",
"       23",
"      </a>",
"      ]. In a study of 15 patients with chronic DPD, compared to subjects with anxiety disorders and healthy controls, DPD subjects exhibited reduced magnitude and increased latency of skin conductance response to unpleasant stimuli, but not to non-specific stimuli, suggesting a selective inhibition of emotional processing. &nbsp;Norepinephrine is a neurotransmitter central to facilitating alertness, selective attention, and enhanced memory encoding under stressful conditions. In a preliminary report, 24-hour urine norepinephrine was found to be strongly inversely correlated to depersonalization severity in nine subjects with DPD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The HPA axis has been investigated in DPD with conflicting findings. &nbsp;While one study reported non-significantly lower basal salivary cortisol in DPD subjects compared to healthy ones [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/25\">",
"       25",
"      </a>",
"      ], the other study reported a tendency for elevated basal urinary and plasma cortisol in DPD compared to healthy controls, with a definite resistance to low-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      suppression suggestive of diminished HPA axis sensitivity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sensory integration occurring in the inferior parietal lobule, in particular in the right hemisphere, has been implicated in out-of-body type experiences [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/27\">",
"       27",
"      </a>",
"      ], and altered activity in this area has been shown in DPD subjects by positron emission tomography scans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypoactivation of the limbic system, in particular the insula, driven by heightened prefrontal inhibition, has been implicated in the hypoemotionality and overthinking of DPD in fMRI studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. Neuroimaging during presentation of trauma scripts has found hyperactivity in prefrontal cortex (PFC) and suppression of activity in amygdala and insula, consistent with this affect suppression theory [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/31\">",
"       31",
"      </a>",
"      ]. Those with the more common hyperarousal form of PTSD show the opposite pattern on fMRI of inhibition of PFC and limbic and insular hyperactivity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The relationship between genes and DPD is not known. An analysis of proband-based family history data in 117 subjects with DPD found a heritability rate of only five percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289542\">",
"    <span class=\"h2\">",
"     Conceptual models",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conceptual models for depersonalization disorder (DPD) have been developed from cognitive-behavioral and psychodynamic perspectives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289549\">",
"    <span class=\"h3\">",
"     Cognitive behavioral model",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cognitive behavioral model proposes that a fear of affect is a central component of DPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/11,32\">",
"     11,32",
"    </a>",
"    ]. Dissociation of affect (&ldquo;not feeling&rdquo;) and alexithymia (difficulty identifying and verbalizing internal emotional states) are seen as core components of the condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/11\">",
"     11",
"    </a>",
"    ]. Depersonalized patients frequently recount traumatic or stressful life experiences in a highly robotic, matter-of-fact, and feelingless way. A distinct subgroup of individuals with posttraumatic stress disorder also suffer from",
"    <span class=\"nowrap\">",
"     depersonalization/derealization",
"    </span>",
"    symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/522?source=see_link\">",
"     \"Dissociative aspects of posttraumatic stress disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute depersonalization represents an almost ubiquitous response to extreme stress. A cognitive framework has been used to describe mechanisms that contribute to the exacerbation and maintenance of the initial symptoms after the stressor lifts, rather than their attenuation and extinction.",
"   </p>",
"   <p>",
"    This cognitive behavioral model proposes that an initial trigger (trauma, anxiety, depression, stress, fatigue, or intoxication) can induce transient symptoms of depersonalization which are subsequently cognitively processed by an individual as either situational or catastrophic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/33\">",
"     33",
"    </a>",
"    ]. If the attributions are situational, and therefore more benign, the depersonalization symptoms will tend to fade as the situational factors lessen. However, if the attributions are catastrophic, they evoke overwhelming fears such as going mad, losing control, becoming invisible, or having a permanent brain dysfunction. In turn, such fears can lead to an increase in anxiety coupled with a paradoxical decrease in arousal, resulting in increased intensity of the depersonalization symptoms as the individual enters the maintenance phase. During this phase, individuals may start to avoid situations that they associate with symptom provocation, become preoccupied with safety behaviors (such as avoidance or &lsquo;acting normal&rsquo;), and develop cognitive biases so that they over-monitor their symptoms and have a reduced threshold for the perception of threat. These maintenance factors thus serve to perpetuate or exacerbate the symptoms over time. &nbsp;",
"    <strong>",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289556\">",
"    <span class=\"h3\">",
"     Psychodynamic model",
"    </span>",
"    &nbsp;&mdash;&nbsp;A psychodynamic understanding of depersonalization phenomena centers around the inability to integrate various aspects of one&rsquo;s self-experience due to external stressors or internal processes that pose an overwhelming challenge to an individual&rsquo;s &ldquo;usual expected&rdquo; sense of self [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/34\">",
"     34",
"    </a>",
"    ]. The self can be conceptualized as having lost its cohesion, so that a &ldquo;physical&rdquo; self, &ldquo;thinking&rdquo; self, &ldquo;feeling&rdquo; self or &ldquo;acting&rdquo; self are poorly integrated with each other leading in discontinuities of various sorts in the experience of the self.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289563\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients experiencing depersonalization often have great difficulty putting their impalpable experiences into words. Unfamiliarity with symptoms of depersonalization may lead individuals to fear that they may be taken for &ldquo;crazy&rdquo; or will become crazy. &nbsp;This is especially common in those raised in homes with severely mentally ill parents. Both these factors, as well as clinicians&rsquo; typical focus on comorbid symptoms such as mood and anxiety, contribute to frequent underdiagnosis or misdiagnosis of depersonalization disorder (DPD).",
"   </p>",
"   <p>",
"    Symptoms, although quite specific, may sound vague or metaphorical rather than clear subjective experiences, such as &ldquo;feeling dead,&rdquo; &ldquo;everything is unreal,&rdquo; &ldquo;I don&rsquo;t feel I&rsquo;m the one doing anything,&rdquo; &ldquo;it&rsquo;s like I&rsquo;m watching a movie&rdquo; etc. The symptoms are typically extremely distressing, at times crippling, and are associated with major morbidity and some mortality. The affectively flattened and robotic demeanor that these patients often demonstrate can also fool the clinician into not recognizing the extreme emotional pain of the condition. It is not uncommon, for example, for patients to wonder whether it would matter if they died. A relative high rate of suicide attempts was associated with DPD; however, given the high rates of comorbid depression and other psychiatric disorders in DPD, the relationship between suicidality and DPD remains unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6,13\">",
"     6,13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2022763\">",
"     'Comorbid conditions'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p>",
"    Two factor analytic studies of the core symptomatology have reported five discrete symptom clusters common in patients with DPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unreality of self, defined as feeling detached from one&rsquo;s physical body, mind and thoughts",
"     </li>",
"     <li>",
"      Perceptual alterations, which encompasses visual, tactile, and somatosensory distortions",
"     </li>",
"     <li>",
"      Emotional numbing, characterized by blunted affect, pain &amp; volition",
"     </li>",
"     <li>",
"      Anomalous subjective recall, which consists of disrupted experiences of time and related imagery",
"     </li>",
"     <li>",
"      Alienation from surroundings, which comprises symptoms of derealization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H692245\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depersonalization disorder (DPD) can have an episodic,",
"    <span class=\"nowrap\">",
"     relapsing/remitting,",
"    </span>",
"    or chronic course. In a series of 117 cases of patients with DPD, approximately one third of individuals had an episodic course; one third had a continuous course from time of onset; and one third initially had an episodic course, which over time became continuous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients with chronic depersonalization experience marked impairment in occupational, social, and personal functioning. In the sample of 117 cases, who had met criteria for DPD for at least three months, the mean age of onset was in late adolescence or early adulthood, with onset of the disorder rarely occurring as late as the fourth or fifth decade of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Onset may be very sudden or insidious. Most patients with DPD are initially treated for secondary anxiety and mood disorder symptoms; the primary nature of the DPD may not be recognized until later. Once chronic depersonalization has set in, new traumatic or stressful events or episodes of other illness may lead to exacerbations of the depersonalization symptoms.",
"   </p>",
"   <p>",
"    Depersonalization that follows traumatic or stressful experiences or intoxication commonly remits acutely and spontaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/3\">",
"     3",
"    </a>",
"    ] In our clinical experience, depersonalization accompanying mood or anxiety disorders commonly remits with definitive treatment of these conditions, especially if treated early in their course. However, in some cases dissociation persists long after the initial precipitants and can become more refractory to treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10289577\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depersonalization disorder (DPD) is diagnosed using the DSM-IV-TR diagnostic criteria for the disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent or recurrent experiences of feeling detached from, and as if one is an outside observer of, one&rsquo;s mental processes or body",
"     </li>",
"     <li>",
"      During the depersonalization experience, reality testing remains intact.",
"     </li>",
"     <li>",
"      The depersonalization causes clinically significant distress or impairment in social, occupational or other important areas of functioning.",
"     </li>",
"     <li>",
"      The depersonalization experience does not occur exclusively during the course of another mental disorder (See",
"      <a class=\"local\" href=\"#H2022362\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A diagnostic assessment of DPD should include a careful assessment for comorbid conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2022763\">",
"     'Comorbid conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    With depersonalization that follows traumatic or stressful experiences or intoxication commonly remitting spontaneously, our clinical experience suggests that it may not be useful or effective to diagnose and treat DPD unless the symptoms continue for a month or possibly longer. The DSM-IV-TR diagnostic criteria for DPD do not specify a minimal duration of symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2022362\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;To diagnose DPD, other mental and physical conditions should be excluded as the cause of depersonalization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H409765\">",
"    <span class=\"h3\">",
"     Mental disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depersonalization can present as a symptom of other mental disorders including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Schizophrenia (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34552?source=see_link\">",
"       \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Panic disorder (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link\">",
"       \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute stress disorder (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7080?source=see_link\">",
"       \"Acute stress disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Posttraumatic stress disorder (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/522?source=see_link\">",
"       \"Dissociative aspects of posttraumatic stress disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other dissociative disorders (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/56/11146?source=see_link\">",
"       \"Dissociative identity disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Borderline and avoidant personality disorders (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10553?source=see_link\">",
"       \"Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A detailed psychiatric history and mental status exam can distinguish DPD from other mental disorders. Primary DPD has an onset and course of depersonalization that is clearly distinct from symptoms of other mental disorders. As an example, a patient with chronic depersonalization has a history of an earlier, frightening episode of severe anxiety that preceded and appeared to precipitate chronic depersonalization. The patient continues to experience depersonalization, even after the initial anxiety has remitted.",
"   </p>",
"   <p>",
"    DPD can be differentiated from psychotic spectrum disorders such as schizophrenia, prodromal schizophrenia, or schizotypal personality disorder by assessing the intactness of reality testing surrounding the perceptual alterations. The differentiation from a prodromal psychotic syndrome can be made based on the presence of perceptual alterations that are not accompanied by magical ideation-type interpretations of the symptoms. As an example, a patient with DPD may feel as if they are dead and simply dreaming their lives. However, if asked whether this were truly so, the patient should be able to reply that they know they are alive in this world.",
"   </p>",
"   <p>",
"    Another feature differentiating DPD from psychotic disorders is that the report of an &ldquo;as if&rdquo; experience of depersonalization typically is not accompanied by distorted cognitive explanations. A study comparing perceptual alterations and magical ideation in patients with DPD and healthy volunteers found that people with the disorder only had elevated perceptual, but not cognitive, distortions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H409772\">",
"    <span class=\"h3\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic depersonalization may less commonly result from a medical or neurological condition (eg, temporal lobe epilepsy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/38,39\">",
"     38,39",
"    </a>",
"    ], or be secondary to substance abuse (most commonly marijuana, hallucinogens,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , and salvia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/13,40\">",
"     13,40",
"    </a>",
"    ]. Rare cases have been seen with vestibular pathology or sleep apnea as the underlying cause. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/1/23578?source=see_link&amp;anchor=H5031012#H5031012\">",
"     \"Localization-related (partial) epilepsy: Causes and clinical features\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=see_link\">",
"     \"Cannabis use disorders: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/13/6359?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of obstructive sleep apnea in adults\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35062?source=see_link\">",
"     \"Vestibular neuritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thorough medical and neurological evaluation should be conducted, including standard laboratory studies (electrolytes, glucose, BUN, Cr), and an EEG. An ambulatory EEG may be indicated in cases of diagnostic ambiguity in the presence of atypical symptoms, such as blanking out, unexplained subtle motor or sensory symptoms, intermittent episodes that are difficult to correlate with any precipitants, a family history of epilepsy, or tumor-related seizure activity.",
"   </p>",
"   <p>",
"    Urine toxicology screening should be performed if history or examination suggests the possibility of substance abuse. An MRI or CT of the brain should be performed in patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age of 40 or greater (See",
"      <a class=\"local\" href=\"#H2022925\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Focal findings on neurologic exam",
"     </li>",
"     <li>",
"      History of head injury",
"     </li>",
"     <li>",
"      Family history of benign or malignant brain tumors",
"     </li>",
"     <li>",
"      Atypical symptoms such as numbness, tingling, or head pressure sensations",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2022867\">",
"    <span class=\"h2\">",
"     Rating scales",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-report questionnaires can be helpful in affirming the diagnosis of DPD, especially for clinicians who are not as extensively familiar with depersonalization symptoms. The very widely used Dissociative Experiences Scale has several items pertaining to",
"    <span class=\"nowrap\">",
"     depersonalization/derealization",
"    </span>",
"    experiences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/41-43\">",
"     41-43",
"    </a>",
"    ] whereas the endorsement of other items pertaining to amnesia and identity alteration should be very infrequent. More specific to the disorder, the Cambridge Depersonalization Scale is a self-report questionnaire comprised of 29 items which rate both frequency and duration of",
"    <span class=\"nowrap\">",
"     depersonalization/derealization",
"    </span>",
"    experiences (",
"    <a class=\"graphic graphic_table graphicRef80001 \" href=\"mobipreview.htm?6/40/6787\">",
"     table 1",
"    </a>",
"    ). A total score of 70 has been shown to reliably differentiate DPD patients from those with various mood, anxiety, or neurological disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32888/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H819630\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depersonalization is a persistent or recurrent feeling of detachment or estrangement from one&rsquo;s self. Depersonalization disorder (DPD) is characterized by the persistence or recurrence of depersonalization, which causes clinically significant distress or impairment, in the presence of intact reality testing. (See",
"      <a class=\"local\" href=\"#H10290103\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transient experiences of depersonalization are very common, while DPD has a prevalence of approximately two percent. DPD has high rates of comorbidity with depression and anxiety disorders as well as avoidant and borderline personality disorders. (See",
"      <a class=\"local\" href=\"#H10289528\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Depersonalization can be precipitated by acute and chronic traumatic experiences. Common organic risk factors for depersonalization include seizures, mild to moderate head injury, and substance abuse. Several neurotransmitter systems, brain areas, and functional circuits have been associated with depersonalization with some consistency in research studies. (See",
"      <a class=\"local\" href=\"#H10289535\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Studies of patients with DPD suggest that five discrete symptoms clusters commonly appear in the disorder (See",
"      <a class=\"local\" href=\"#H10289563\">",
"       'Clinical manifestations'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Unreality of self",
"     </li>",
"     <li>",
"      Perceptual alterations",
"     </li>",
"     <li>",
"      Emotional numbing",
"     </li>",
"     <li>",
"      Anomalous subjective recall",
"     </li>",
"     <li>",
"      Alienation from surroundings",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of depersonalization includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Other psychiatric disorders that can cause depersonalization: acute stress disorder, posttraumatic stress disorder, depression, panic disorder and other anxiety disorders, borderline and avoidant personality disorders and other dissociative disorders.",
"     </li>",
"     <li>",
"      General medical conditions: temporal lobe epilepsy, mild to moderate brain trauma",
"     </li>",
"     <li>",
"      Substance abuse: marijuana, hallucinogens,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      , and salvia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H2022362\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), Fourth edition, Text revision, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     Cattell JP, Cattell JS. Depersonalization: Psychological and social perspectives. In: American Handbook of Psychiatry, Arieti S.  (Ed), Basic Books, New York 1974.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/3\">",
"      Aderibigbe YA, Bloch RM, Walker WR. Prevalence of depersonalization and derealization experiences in a rural population. Soc Psychiatry Psychiatr Epidemiol 2001; 36:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/4\">",
"      Ross CA, Joshi S, Currie R. Dissociative experiences in the general population: a factor analysis. Hosp Community Psychiatry 1991; 42:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/5\">",
"      Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol 2004; 39:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/6\">",
"      Simeon D, Knutelska M, Nelson D, Guralnik O. Feeling unreal: a depersonalization disorder update of 117 cases. J Clin Psychiatry 2003; 64:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/7\">",
"      Baker D, Hunter E, Lawrence E, et al. Depersonalisation disorder: clinical features of 204 cases. Br J Psychiatry 2003; 182:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/8\">",
"      Noyes R Jr, Hoenk PR, Kuperman S, Slymen DJ. Depersonalization in accident victims and psychiatric patients. J Nerv Ment Dis 1977; 164:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/9\">",
"      Noyes R Jr, Kletti R. Depersonilization in response to life-threatening danger. Compr Psychiatry 1977; 18:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/10\">",
"      Simeon D, Guralnik O, Schmeidler J, et al. The role of childhood interpersonal trauma in depersonalization disorder. Am J Psychiatry 2001; 158:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/11\">",
"      Simeon D, Giesbrecht T, Knutelska M, et al. Alexithymia, absorption, and cognitive failures in depersonalization disorder: a comparison to posttraumatic stress disorder and healthy volunteers. J Nerv Ment Dis 2009; 197:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/12\">",
"      Grigsby J, Kaye K. Incidence and correlates of depersonalization following head trauma. Brain Inj 1993; 7:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/13\">",
"      Simeon D, Kozin DS, Segal K, Lerch B. Is depersonalization disorder initiated by illicit drug use any different? A survey of 394 adults. J Clin Psychiatry 2009; 70:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/14\">",
"      Simeon D. Depersonalisation disorder: a contemporary overview. CNS Drugs 2004; 18:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/15\">",
"      Anand A, Charney DS, Oren DA, et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000; 57:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/16\">",
"      Deakin JF, Lees J, McKie S, et al. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 2008; 65:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/17\">",
"      Mathew RJ, Wilson WH, Chiu NY, et al. Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 1999; 100:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/18\">",
"      Feigenbaum JJ, Bergmann F, Richmond SA, et al. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci U S A 1989; 86:9584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/19\">",
"      Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 2001; 299:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/20\">",
"      Simeon D, Hollander E, Stein DJ, et al. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Res 1995; 58:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/21\">",
"      Southwick SM, Krystal JH, Bremner JD, et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1997; 54:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/22\">",
"      D'Souza DC, Gil RB, Zuzarte E, et al. gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation. Biol Psychiatry 2006; 59:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/23\">",
"      Sierra M, Senior C, Dalton J, et al. Autonomic response in depersonalization disorder. Arch Gen Psychiatry 2002; 59:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/24\">",
"      Simeon D, Guralnik O, Knutelska M, et al. Basal norepinephrine in depersonalization disorder. Psychiatry Res 2003; 121:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/25\">",
"      Stanton BR, David AS, Cleare AJ, et al. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Res 2001; 104:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/26\">",
"      Simeon D, Knutelska M, Yehuda R, et al. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry 2007; 61:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/27\">",
"      Blanke O, Ortigue S, Landis T, Seeck M. Stimulating illusory own-body perceptions. Nature 2002; 419:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/28\">",
"      Simeon D, Guralnik O, Hazlett EA, et al. Feeling unreal: a PET study of depersonalization disorder. Am J Psychiatry 2000; 157:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/29\">",
"      Phillips ML, Medford N, Senior C, et al. Depersonalization disorder: thinking without feeling. Psychiatry Res 2001; 108:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/30\">",
"      Lemche E, Surguladze SA, Giampietro VP, et al. Limbic and prefrontal responses to facial emotion expressions in depersonalization. Neuroreport 2007; 18:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/31\">",
"      Lanius RA, Vermetten E, Loewenstein RJ, et al. Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. Am J Psychiatry 2010; 167:640.",
"     </a>",
"    </li>",
"    <li>",
"     Simeon D, Abugel J. Feeling Unreal: Depersonalization Disorder and the Loss of the Self, Oxford University Press, New York 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/33\">",
"      Hunter EC, Phillips ML, Chalder T, et al. Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther 2003; 41:1451.",
"     </a>",
"    </li>",
"    <li>",
"     Simeon D, Abugel J. Feeling Unreal: Depersonalization disorder and the loss of self, Oxford University Press, New York 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/35\">",
"      Sierra M, Baker D, Medford N, David AS. Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol Med 2005; 35:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/36\">",
"      Simeon D, Kozin DS, Segal K, et al. De-constructing depersonalization: further evidence for symptom clusters. Psychiatry Res 2008; 157:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/37\">",
"      Simeon D, Guralnik O. Dissection of schizotypy and dissociation in depersonalization disorder. J Trauma and Dissociation 2004; 5:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/38\">",
"      Lambert MV, Senior C, Fewtrell WD, et al. Primary and secondary depersonalisation disorder: a psychometric study. J Affect Disord 2001; 63:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/39\">",
"      Sierra M, Lopera F, Lambert MV, et al. Separating depersonalisation and derealisation: the relevance of the \"lesion method\". J Neurol Neurosurg Psychiatry 2002; 72:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/40\">",
"      Medford N, Baker D, Hunter E, et al. Chronic depersonalization following illicit drug use: a controlled analysis of 40 cases. Addiction 2003; 98:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/41\">",
"      Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986; 174:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/42\">",
"      Bernstein-Carlson E, Putnam FW. An update on the Disssociative Experiences Scale. Dissociation 1993; 6:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/43\">",
"      van Ijzendoorn MH, Schuengel C. The measurement of dissociation in normal and clinical populations: meta-analytic validation of the dissociative experiences scale (DES). Clin Psychol Rev 1996; 16:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32888/abstract/44\">",
"      Sierra M, Berrios GE. The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization. Psychiatry Res 2000; 93:153.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16700 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-F1BE05E961-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32888=[""].join("\n");
var outline_f32_7_32888=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H819630\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10290103\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10289528\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2022939\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2022925\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2022763\">",
"      Comorbid conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10289535\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H820260\">",
"      Role of trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H253900\">",
"      Organic precursors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H409471\">",
"      Neurobiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10289542\">",
"      Conceptual models",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10289549\">",
"      - Cognitive behavioral model",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10289556\">",
"      - Psychodynamic model",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10289563\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H692245\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10289577\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2022362\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H409765\">",
"      - Mental disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H409772\">",
"      - Other conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2022867\">",
"      Rating scales",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H819630\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/16700\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/16700|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/40/6787\" title=\"table 1\">",
"      Cambridge depersonalization scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7080?source=related_link\">",
"      Acute stress disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10553?source=related_link\">",
"      Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=related_link\">",
"      Cannabis use disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/522?source=related_link\">",
"      Dissociative aspects of posttraumatic stress disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/56/11146?source=related_link\">",
"      Dissociative identity disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/1/23578?source=related_link\">",
"      Localization-related (partial) epilepsy: Causes and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/13/6359?source=related_link\">",
"      Overview of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=related_link\">",
"      Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34552?source=related_link\">",
"      Schizophrenia: Clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/55/21367?source=related_link\">",
"      Treatment of depersonalization disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35062?source=related_link\">",
"      Vestibular neuritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32889="Evaluation of cervical spine injuries in children and adolescents";
var content_f32_7_32889=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of cervical spine injuries in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     Alison Chantal Caviness, MD, MPH, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/7/32889/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/7/32889/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical spine injury is rare in children. It is seen primarily in those who sustain significant, severe blunt trauma, occurring in 1 to 2 percent of such cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The injury may involve bones, ligaments, blood vessels, or the spinal cord, and must be rapidly recognized and treated to avoid permanent disability or death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/3\">",
"     3",
"    </a>",
"    ]. Any child who is suspected of having a cervical spine injury must be correctly immobilized in a neutral position until the injury is excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/4\">",
"     4",
"    </a>",
"    ]. The diagnosis or high suspicion of cervical spine injury requires prompt consultation with a neurosurgeon.",
"   </p>",
"   <p>",
"    The evaluation of cervical spine injuries in children and adolescents is reviewed here. Techniques for immobilization of the pediatric cervical spine are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of cervical spine injuries in adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31274?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and acute management of cervical spinal column injuries in adults\", section on 'Radiographic evaluation of cervical spinal column injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children younger than eight years of age are more susceptible to injury of the upper cervical spine (C1 to C3) than older children and adults because of certain features of their anatomic development (",
"    <a class=\"graphic graphic_table graphicRef55343 \" href=\"mobipreview.htm?2/31/2555\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/2,3,5-8\">",
"     2,3,5-8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They have relatively larger heads than bodies. The head circumference of a child reaches 50 percent of adult size by two years of age; in contrast, the chest circumference reaches 50 percent of adult size by eight years of age.",
"     </li>",
"     <li>",
"      The position of the cervical spine fulcrum progresses caudally from C2-3 at birth to C5-6 at eight years of age.",
"     </li>",
"     <li>",
"      They have weaker cervical musculature and increased laxity of the ligaments, resulting in greater mobility of the upper cervical spine.",
"     </li>",
"     <li>",
"      They have immature vertebral joints and horizontally inclined articulating facets that facilitate sliding of the upper cervical spine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, younger children may also incur fractures of the growth plate and ligamentous injuries (subluxation and distraction) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/9\">",
"     9",
"    </a>",
"    ]. Two factors may contribute to this problem:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The immature growth centers are susceptible to sheer forces during rapid deceleration or hyperflexion-extension, particularly at the synchondrosis between the odontoid and vertebral body of C-2.",
"     </li>",
"     <li>",
"      The young spinal column is more elastic than is the spinal cord and is able to tolerate more distraction before rupture (up to 5 cm versus only 5 to 6 mm in the spinal cord). Thus, spinal cord injury can occur without radiographic evidence of spinal column injury. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=see_link\">",
"       \"Spinal cord injury without radiographic abnormality (SCIWORA) in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common injuries in older children are vertebral body and arch fractures. These fractures usually are in the lower cervical spine; such injuries are less common in children younger than eight years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cervical spine injuries are evident by history or physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/1,5,13-16\">",
"     1,5,13-16",
"    </a>",
"    ]. The elements in the history that suggest the likelihood of cervical spine injury include the cause of trauma, the mechanism of injury, and the presence of symptoms at any time after the injury, even if they have resolved.",
"   </p>",
"   <p>",
"    Cervical spine injury must be suspected in all children who are severely injured or have high-risk injuries. Serious head injury and multiple-system trauma are commonly associated with spinal injuries and may distract the child (and medical provider) from recognizing and appreciating cervical pain or other important symptoms. In addition, cervical spine injury should be suspected in those children who have an underlying predisposition to such injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Down syndrome (approximately 15 percent have atlantoaxial instability) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=see_link\">",
"       \"Clinical features and diagnosis of Down syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      History of cervical spine surgery",
"     </li>",
"     <li>",
"      History of cervical spine arthritis",
"     </li>",
"     <li>",
"      Klippel-Feil syndrome (congenital fusion of variable numbers of cervical vertebrae and associated defects including scoliosis, renal anomalies, elevated scapula (Sprengel deformity), congenital heart disease, and deafness)",
"     </li>",
"     <li>",
"      Morquio syndrome (mucopolysaccharidosis IV) (",
"      <a class=\"graphic graphic_picture graphicRef59486 \" href=\"mobipreview.htm?26/8/26754\">",
"       picture 1",
"      </a>",
"      ), which is associated with hypoplasia of the odontoid (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79215 \" href=\"mobipreview.htm?4/5/4191\">",
"       image 1",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/6/7274?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical features and diagnosis of the mucopolysaccharidoses\", section on 'MPS type IV (Morquio syndrome)'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Larsen syndrome, which may have associated cervical vertebrae hypoplasia and is otherwise characterized by multiple joint dislocations, flat facies, and short fingernails",
"     </li>",
"     <li>",
"      Other syndromes affecting the cervical spine",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cause of trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of cervical spine injuries result from trauma to the top of the head or back of the neck. The most common causes of cervical spine injury vary by age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/5,9,12\">",
"     5,9,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Birth &ndash; Vaginal delivery of infants in the breech position",
"     </li>",
"     <li>",
"      Birth to eight years &ndash; Motor vehicle crashes (MVCs) and falls",
"     </li>",
"     <li>",
"      Older than eight years &ndash; MVCs and sports injuries",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The major causes of cervical spine injury include trauma that is associated with [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe force (eg, motor vehicle crash or fall of a distance that is greater than the child's height) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/52/12106?source=see_link&amp;anchor=H2#H2\">",
"       \"Prevention of falls in children\", section on 'Falls from height'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Diving",
"     </li>",
"     <li>",
"      Acceleration-deceleration of the head (eg, hitting the head on the dashboard during a head-on collision)",
"     </li>",
"     <li>",
"      Multiple system trauma",
"     </li>",
"     <li>",
"      Certain sports (eg, football, hockey, wrestling)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Mechanism of injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical spine injury can occur through flexion, extension, vertical compression, rotation, or a combination of these. Most spinal cord injuries result from direct compression or disruption of the cord by fracture fragments or subluxed vertebrae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/13\">",
"     13",
"    </a>",
"    ]. It is prudent to suspect cervical spine injury based upon the mechanism of injury for children younger than three years because they typically are unable to provide a history and cooperate with the examination.",
"   </p>",
"   <p>",
"    The mechanism of injury may predict the type of injury and the radiologic findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperflexion injuries are the most common and may cause wedge fractures of the anterior vertebral body with disruption of the posterior elements (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75142 \" href=\"mobipreview.htm?15/61/16337\">",
"       image 2",
"      </a>",
"      ). Examples include the clay-shoveler's fracture, an avulsion fracture of the base of the spinous process of C6, C7, or T1, and the teardrop fracture with anterior displacement of a triangular bony fragment of the anteroinferior portion of the vertebral body.",
"     </li>",
"     <li>",
"      Hyperextension injuries may cause compression of the posterior elements and disruption of the anterior longitudinal ligament. An example is the hangman's fracture of the posterior neural arch of C1 or the pedicles of C2 (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65350 \" href=\"mobipreview.htm?21/63/22513\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Axial loading may cause burst or comminuted fractures of the arches of C1 in the upper cervical spine or of the vertebral bodies in the lower cervical spine. The Jefferson burst fracture, for example, consists of fractures of the arches of C1 and lateral displacement of C1 with respect to C2. Axial loading also may cause compression fractures of the vertebra (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54151 \" href=\"mobipreview.htm?40/39/41585\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Rotational injuries may cause fracture or dislocation of the facets. These injuries are uncommon in isolation and occur more frequently in combination with flexion or extension injuries.",
"     </li>",
"     <li>",
"      Chin trauma may provide a clue to cervical spine injury since the force of injury may be transmitted to the jaw and cervical spine. Chin trauma, fractures of the posterior teeth and mandibular condyles, and cervical spine injury have been described as progressive components of a single injury pattern [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/22\">",
"       22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6615?source=see_link\">",
"       \"Jaw fractures in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who have symptoms suggestive of spinal injury should have immobilization maintained during initial evaluation and management and undergo rapid radiologic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/44/6854?source=see_link&amp;anchor=H3#H3\">",
"     \"Pediatric cervical spine immobilization\", section on 'Method'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11\">",
"     'Radiologic evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The classic triad of symptoms includes local pain, muscle spasm, and decreased range of motion of the neck. Patients also may complain of transient or persistent paresthesias or weakness. The distribution of transient symptoms is variable and ranges from involvement of the hands or feet to dramatic neurologic deficits, including quadriplegia. The patient's ability to walk does not exclude cervical spine injury because some patients with cervical spine injuries are able to walk immediately after the event.",
"   </p>",
"   <p>",
"    Not all children who have spinal cord injuries complain of symptoms; some are asymptomatic, whereas others are unable to express their symptoms (eg, preverbal or severely injured) or have a distracting injury. A retrospective review of 72 previously normal children with cervical spine injury found that all those with asymptomatic injuries had both a high-risk injury mechanism and a distracting injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The history should include the presence of symptoms at any time after the injury, even if they have resolved. Transient burning dysesthesias in the hands and fingers may indicate hyperextension of the cervical spine with central cord contusion. This is the \"burning hands\" syndrome that has been observed in football players [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Cervical cord neurapraxia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transient symptoms (eg, paresthesias, weakness) also may be the only indication of spinal cord injury without radiographic abnormality (SCIWORA). Thus, it is critical to have a high index of suspicion and to ask specifically about transient symptoms in any patient whose mechanism of injury is consistent with potential cervical spine injury. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=see_link&amp;anchor=H26107906#H26107906\">",
"     \"Spinal cord injury without radiographic abnormality (SCIWORA) in children\", section on 'Clinical features'",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal elements of the physical examination of a child suspected of having a cervical spine injury are the vital signs, neck examination, and neurologic examination. The cervical collar may be removed for examination if the patient has no symptoms suggestive of spinal cord injury (",
"    <a class=\"graphic graphic_algorithm graphicRef70732 \" href=\"mobipreview.htm?12/52/13134\">",
"     algorithm 1",
"    </a>",
"    ). The collar must be replaced and radiologic evaluation must ensue if any abnormalities suggestive of cervical spine injury are detected during the examination.",
"   </p>",
"   <p>",
"    Some toddlers and infants can be clinically cleared after minor trauma if they have a normal neurologic examination (including mental status) and no distracting injuries; in such circumstances, the c-spine can be carefully palpated and active ROM can be assessed. Decreased ROM of the neck or apparent tenderness requires re-immobilization and imaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea or hypoventilation may result from injuries at the spinal level of diaphragmatic control (C3, C4, C5). Hypotension, bradycardia, or temperature instability may result from spinal shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Neck examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinous processes are palpated for local tenderness, muscle spasm, or obvious deformity while inline stabilization of the neck is maintained. With a cervical spine injury, midline cervical tenderness is more common than paraspinous muscular spasm or tenderness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neurologic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A neurologic examination should be completed with evaluation of tone, strength, sensation, and reflexes. Up to 50 percent of children with cervical cord injuries have neurologic deficits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/1,24\">",
"     1,24",
"    </a>",
"    ]. The neurologic findings that correspond to spinal injury at different levels are presented in Table 2 and Figure 1 (",
"    <a class=\"graphic graphic_table graphicRef63597 \" href=\"mobipreview.htm?23/43/24253\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63098 \" href=\"mobipreview.htm?16/26/16807\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=see_link&amp;anchor=H10928992#H10928992\">",
"     \"Detailed neurologic assessment of infants and children\", section on 'Neurologic examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flaccid muscle tone indicates a lower motor neuron lesion or spinal cord disruption.",
"     </li>",
"     <li>",
"      Muscle strength is best evaluated by testing dorsiflexion of the wrist (C6), extension of the elbow (C7), extension of the knee (L2-L4), and dorsiflexion of the great toe (L5).",
"     </li>",
"     <li>",
"      An isolated sensory deficit is the most common neurologic finding in patients with cervical spine injury. The level of sensory impairment localizes the level of injury. The ipsilateral posterior spinal column and contralateral anterior column are tested with light touch. The anterolateral spinal column is tested with pinprick (pain), and the ipsilateral posterior spinal column is tested with position sense.",
"     </li>",
"     <li>",
"      Deep tendon reflexes should be tested. Areflexia indicates spinal cord injury, which is the transient (usually lasting less than 24 hours) depression of reflexes below the level of the injury. The level of abnormality may localize the injury.",
"     </li>",
"     <li>",
"      The absence of tone on rectal examination is a poor prognostic sign. The absence of the bulbocavernosus reflex indicates spinal shock. The bulbocavernosus reflex (S3-S4) is performed by squeezing the glans penis, tapping on the mons pubis, or by pulling on a urinary catheter while performing a rectal examination. These maneuvers normally stimulate the trigone of the bladder, causing a reflex contraction of the anal sphincter; a lack of response and flaccid sphincter tone indicate significant spinal cord injury or damage to the sacral elements of the spinal cord.",
"     </li>",
"     <li>",
"      Paralysis may be difficult to evaluate in infants and children. The level of paralysis, if present, localizes the injury. Mass withdrawal movements may occur as a reflex in infants or children with paralysis and may complicate the evaluation in the immediate post injury phase.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several syndromes that suggest specific types of injuries are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anterior cord syndromes result from hyperflexion and anterior cord compression. Paralysis and loss of pain sensation without loss of light touch or proprioception sense below the level of injury occur. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H5#H5\">",
"       \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Anterior cord syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Central cord syndromes result from hyperextension injuries. They are associated with weakness that is greater in the upper than in the lower extremities and transient burning sensation in the hands and fingers. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H4#H4\">",
"       \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Central cord syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The Brown-S&eacute;quard syndrome results from cord hemisection. It is associated with ipsilateral paralysis, loss of proprioception, and loss of light touch and contralateral loss of pain and temperature sense. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H6#H6\">",
"       \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Brown-S&eacute;quard syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Horner's syndrome results from disruption of the sympathetic chain. It is associated with ipsilateral ptosis, miosis, and anhidrosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/32/32262?source=see_link\">",
"       \"Horner's syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with suspected cervical spine injury based on history or physical examination must undergo radiologic evaluation. At a minimum, radiologic evaluation should include three views (cross-table lateral, AP, and, when obtainable, open-mouth odontoid). Depending on whether abnormal findings are present on physical examination or plain radiographs, computed tomography (CT), magnetic resonance imaging, or both may also be indicated. CT may also be necessary when adequate plain radiographic views cannot be obtained.",
"   </p>",
"   <p>",
"    Children with clinical findings suggestive of spinal cord injury must be treated as if they have one, even if the radiologic evaluation is normal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=see_link&amp;anchor=H26107927#H26107927\">",
"     \"Spinal cord injury without radiographic abnormality (SCIWORA) in children\", section on 'Initial Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The historical and physical findings that direct radiologic evaluation are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef79881 \" href=\"mobipreview.htm?9/11/9405\">",
"     table 3",
"    </a>",
"    ). As discussed above, the mechanism of injury may predict the type of injury and the radiologic findings. When indicated, radiographs must be evaluated carefully for injuries of C1 to C3, including odontoid fractures, atlantoaxial dislocations or subluxations, and hyperextension fractures of the axis.",
"   </p>",
"   <p>",
"    Efforts have been made to define the characteristics of children for whom radiographic evaluation is not necessary:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective review of 206 children younger than 16 years of age, who presented with trauma and had cervical spine radiographs, was performed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/13\">",
"       13",
"      </a>",
"      ]. Eight variables were predictive of cervical spine injury: neck pain, neck tenderness, limitation of neck mobility, history of trauma to the neck, and abnormalities of reflexes, strength, sensation, or mental status. The presence of one of these findings had a sensitivity of 98 percent and a specificity of 54 percent. Radiographs could safely have been avoided in 38 percent of the study population.",
"     </li>",
"     <li>",
"      A multicenter, prospective study evaluated the ability of a set of clinical criteria (commonly known as the NEXUS criteria) to identify patients with a low probability of cervical spine injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/25\">",
"       25",
"      </a>",
"      ]. Patients were required to meet all five criteria: no midline cervical tenderness, no focal neurologic deficit, normal alertness, no intoxication, and no painful, distracting injury. The decision set had a sensitivity of 99 percent (95% CI, 98-99.6). The findings of this study cannot be generalized to the pediatric population because only 2.5 percent of the patients were younger than eight years of age.",
"     </li>",
"     <li>",
"      A large, prospective, multicenter trial evaluated the NEXUS criteria for obtaining cervical spine radiographs in 3065 pediatric trauma victims (88 children younger than two years, 817 children between two and eight years, and 2817 between the ages of 8 and 17 years) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/26\">",
"       26",
"      </a>",
"      ]. Thirty children had cervical spine injuries; all of them had at least one risk factor; none of the children without risk factors had cervical spine injury. However, only four of the children with spinal injury were younger than nine years, and none were younger than two years. These results indicate that the NEXUS criteria can safely be applied to children older than eight years, but cannot yet be generalized to younger children.",
"     </li>",
"     <li>",
"      A multicenter observational study of 12,537 children less than three years of age who sustained blunt trauma and were evaluated in a designated trauma center found that approximately one-third of patients were clinically cleared without any imaging [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/27\">",
"       27",
"      </a>",
"      ]. Cervical spine injury was diagnosed in 83 patients (0.66 percent) who underwent either plain radiograph or cervical spine computed tomography, and none of these injuries were missed during the initial evaluation. Independent predictors of cervical spine injury in these children included a Glasgow coma scale (GCS) &lt;14, eye opening subscore on the GCS of 1, age 24 to 36 months, and involvement in a motor vehicle collision. These criteria had a sensitivity for cervical spine injury of 93 percent (95% CI: 85-97 percent). The negative predictive value for cervical spine injury in children with normal mental status who were not involved in a motor vehicle collision was 99.93 percent (95% CI 99.85 &ndash; 99.97 percent).",
"     </li>",
"     <li>",
"      A multicenter observational study of 575 children &le;3 years of age, who were evaluated during trauma activations at a level one trauma center, found that a normal physical examination and plain radiographs were sufficient to exclude cervical spine injury in 491 patients (85 percent, data provided by author) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/28\">",
"       28",
"      </a>",
"      ]. Cervical spine injuries were found in 28 patients (3.3 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three-view spine series (cross-table lateral, AP, and, when obtainable, open-mouth odontoid) provides the most sensitive evaluation of cervical spine stability. Cross-table lateral views identify approximately 80 percent of fractures, dislocations, and subluxations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/29\">",
"     29",
"    </a>",
"    ]. The addition of the AP and when obtainable, odontoid views, increases the sensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/5\">",
"     5",
"    </a>",
"    ]. Obtaining a suitable cervical-spine series is extremely important; the most frequent cause of a missed or unappreciated vertebral body injury is an inadequate film series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of plain radiography to screen for cervical spine injury was evaluated in a multicenter, prospective observational study (the National Emergency X-Radiography Utilization Study project [NEXUS]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/31\">",
"     31",
"    </a>",
"    ]. Almost 35,000 patients (aged 1 month to 101 years) were enrolled, including 818 patients with 1496 cervical spine injuries. The sensitivity of an adequate three-view series was 89.4 percent. The majority of false-negative results occurred in cases in which the plain radiographs were interpreted as abnormal (but not diagnostic of injury) or inadequate.",
"   </p>",
"   <p>",
"    The interpretation of cervical spine radiographs in children may be difficult. Although the bony anatomy of the pediatric cervical spine is similar to that of an adult by 8 to 10 years of age, radiographic findings may differ until 15 years of age. In younger children, avulsions and epiphyseal separation are more common than are fractures. Finally, normal anatomic variants of the cervical spine in children (such as absence of cervical lordosis, incomplete ossification of the posterior elements, ligamentous laxity, and pseudosubluxation of C2 on C3) must be distinguished from pathological findings (",
"    <a class=\"graphic graphic_table graphicRef71839 \" href=\"mobipreview.htm?5/57/6043\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/7,10,32,33\">",
"     7,10,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Lateral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete evaluation of the lateral cervical spine requires that all seven cervical vertebrae be visualized. Gentle traction on the arms or a transaxillary (swimmer's) view may be necessary to bring C7 and T1 into view. However, the swimmer&rsquo;s view should not be performed if there is a high likelihood of cervical spine injury. The bony integrity, alignment, and cartilaginous and soft tissue spaces of the cervical spine should be systematically evaluated. Any abnormality of these elements indicates the possibility of fracture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ligamentous injury.",
"   </p>",
"   <p>",
"    Bony structures of the cervical spine can be readily identified on a lateral radiograph. The following abnormalities indicate a cervical spine injury:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fractures, displacements, subluxations, and dislocations",
"     </li>",
"     <li>",
"      Alterations of height or uniformity of disc spaces",
"     </li>",
"     <li>",
"      Overriding of the facets",
"     </li>",
"     <li>",
"      Rotation of the spinous processes of the vertebral bodies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Disruption of the alignment of the four curvilinear cervical spine contour lines (the anterior vertebral body line, the posterior vertebral body line, the spinolaminar line, and the tips of the spinous processes) identified on a lateral radiograph may indicate one of the following (",
"    <a class=\"graphic graphic_figure graphicRef64818 \" href=\"mobipreview.htm?20/51/21297\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Muscle spasm can cause disruption of the lordotic curve. However, lordosis may be normally absent in children up to the age of 15 years.",
"     </li>",
"     <li>",
"      Pseudosubluxation (C2 on C3 only) can be differentiated from true subluxation by evaluating the posterior cervical (Swischuk) line between the anterior aspects of the C1 and C3 spinous processes (",
"      <a class=\"graphic graphic_figure graphicRef63065 \" href=\"mobipreview.htm?21/27/21944\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/34\">",
"       34",
"      </a>",
"      ]. True subluxation should be suspected if the posterior cervical line misses the anterior aspect of the C2 spinous process by 2 mm or more.",
"     </li>",
"     <li>",
"      With ligamentous disruption, the tips of the spinous processes may not align uniformly.",
"     </li>",
"     <li>",
"      An unstable occipitoatlantoaxial injury, which is associated with disruption of the tectorial membrane, is suggested when the distance between the spinous processes of C1 and C2 is increased (",
"      <a class=\"graphic graphic_figure graphicRef62857 \" href=\"mobipreview.htm?35/2/35876\">",
"       figure 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The latter was demonstrated in a retrospective review describing children with occipitoatlantoaxial injury. An interspinous ratio (C1-2:C2-3) was calculated by measuring the shortest distance between the inferior cortex of the spinous process of C1 and the superior cortex of the spinous process of C2 (C1-2) and dividing it by the shortest distance between the inferior cortex of the C2 spinous process and the superior cortex of the C3 spinous process (C2-3) (",
"    <a class=\"graphic graphic_figure graphicRef62857 \" href=\"mobipreview.htm?35/2/35876\">",
"     figure 4",
"    </a>",
"    ). A ratio of 2.5 or more had a sensitivity of 87 percent and a specificity of 100 percent for detecting tectorial membrane injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/11,36\">",
"     11,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Soft tissue spaces that should be evaluated on a lateral cervical spine radiograph include the predental space and the prevertebral space. The predental space is between the posterior surface of the anterior arch of C1 and the anterior surface of odontoid process (dens) of C2. In children younger than eight years, the predental space should be no more than 4 to 5 mm (3 mm in adults) and the prevertebral space at C3, C4 should be no more than one-third the AP diameter of the vertebral body (7 mm in adults) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Widening of the predental space suggests underlying blood or edema, often secondary to atlantoaxial instability, Jefferson fracture, or atlantoaxial rotational subluxation.",
"     </li>",
"     <li>",
"      Widening of the prevertebral space suggests hematoma, abscess, or bony injury. However, the space also may appear widened in exhalation (crying child), flexion (uncooperative child), or the presence of a nasogastric or endotracheal tube.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Anterior-posterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anterior-posterior (AP) view may identify lateral mass fractures that are not identified on lateral films (eg, isolated oblique pillar or isolated transverse process fractures). In this view, the spinous processes should be well aligned in the midline.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Odontoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;The odontoid process (dens) and body of C2 between the lateral masses of C1 are best visualized with the open-mouth odontoid view in children &ge;9 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/39-41\">",
"     39-41",
"    </a>",
"    ] and through the foramen on the Waters' view in younger children who cannot cooperate with an open-mouth view.",
"   </p>",
"   <p>",
"    The dens should be examined for any longitudinal or transverse fractures. The lateral aspects of C1 should be symmetric, and they should have equal amounts of space on both sides of the dens. The lateral aspects of C1 also should line up with the lateral aspects of C2.",
"   </p>",
"   <p>",
"    Odontoid fractures are classified according to their location. Type 1 fractures are at the apex of the dens, type 2 are most common and are at the waist of the dens, and type 3 extend into the body of C2. Bilateral widening between the dens and the lateral masses is consistent with a Jefferson fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Flexion-extension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexion-extension plain radiograph views usually add little to the acute evaluation of patients with blunt trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/42\">",
"     42",
"    </a>",
"    ]. In the past, these views were used to identify cervical instability, atlantoaxial joint instability, and ligamentous injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. They may be useful in the rare instances when the three view cervical spine series and computed tomography are negative despite the presence of cervical pain, tenderness, or spasm. In the NEXUS study described above, 2 of the 818 patients with cervical spine injuries had stable bony injuries that were detected only with flexion-extension views. Another four patients had subluxation detected on flexion-extension views; they all had other injuries that were apparent with routine cervical spine imaging.",
"   </p>",
"   <p>",
"    Flexion-extension views require the cooperation of the patient; they must be done only with active flexion and extension that is stopped if the patient has pain. Passive or painful flexion or extension should never be performed because they may precipitate or worsen spinal cord injury. Obtaining radiographs subacutely, after muscle spasm subsides, may be necessary to detect occult ligamentous injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Oblique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oblique views add little information to the three-view series and rarely are indicated in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/46\">",
"     46",
"    </a>",
"    ]. They may be better at demonstrating pedicle, posterior laminar, or articular mass fractures and may improve visualization of facet alignment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/47\">",
"     47",
"    </a>",
"    ]. However, the additional utility of oblique views in children, particularly if the AP and lateral views are normal, has been questioned [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/48\">",
"     48",
"    </a>",
"    ]. Oblique views are not usually recommended in the evaluation of pediatric cervical spine injuries. If obliques are obtained, they should be performed by moving the radiologic equipment, NOT by patient movement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine use of CT for the initial evaluation of cervical spine injuries in children is not justified for the following reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/2,49-56\">",
"     2,49-56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A helical cervical spine CT delivers 50 percent increase in mean radiation dose to the cervical spine in pediatric patients relative to conventional radiography [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/53\">",
"       53",
"      </a>",
"      ]. In addition, the radiation dose to the skin and thyroid for CT evaluation of the cervical spine is approximately 10 times and 14 times, respectively, that of a five view cervical spine series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/52,57\">",
"       52,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children, especially those younger than five years, are more prone to radiation induced malignancies due to increased radiosensitivity of certain organs and a longer time during which to develop a cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/54\">",
"       54",
"      </a>",
"      ]. Estimated lifetime cancer mortality risks attributable to the radiation exposure from a CT for a one year old is approximately 0.07 to 0.18 percent, which is a risk that is an order of magnitude higher than that for adults who are exposed to a CT of the cervical spine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT is more costly than plain radiography.",
"     </li>",
"     <li>",
"      Although cervical spine CT has high diagnostic utility for bony injuries, it is not ideal for ligamentous injuries that are more common in children than in adults [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the sensitivity and specificity of CT for detecting cervical spine bony injury are 98 percent or better [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/49,58\">",
"     49,58",
"    </a>",
"    ]. It is therefore a valuable adjunct for identifying an injury in some patients who require radiographic evaluation (",
"    <a class=\"graphic graphic_table graphicRef79881 \" href=\"mobipreview.htm?9/11/9405\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A CT should be obtained in any of the following circumstances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inadequate cervical spine radiographs (three views in children over three years of age, inadequate lateral or open mouth view in children under three years of age), especially if there is a high likelihood of injury based on mechanism or physical findings",
"     </li>",
"     <li>",
"      Suspicious plain radiographic findings",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Fracture/displacement",
"      </span>",
"      seen on plain radiographs",
"     </li>",
"     <li>",
"      High clinical index of suspicion of injury despite normal radiographs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) is the imaging procedure of choice in any patient with neurologic signs or symptoms and normal plain radiographs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/61\">",
"     61",
"    </a>",
"    ]. MRI is superior to CT for visualizing soft tissues and identifying intervertebral disk herniation, ligamentous injuries and spinal cord edema, hemorrhage, compression, and transection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/62-69\">",
"     62-69",
"    </a>",
"    ]. Spinal cord injury without radiographic abnormality (SCIWORA) was defined in 1982 as objective signs of myelopathy as a result of trauma in the absence of findings on plain radiographs, flexion-extension radiographs, and cervical CT. However, with MRI, most cases previously described as SCIWORA actually have demonstrable injury to the spinal cord or spinal cord ligaments. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=see_link&amp;anchor=H26107920#H26107920\">",
"     \"Spinal cord injury without radiographic abnormality (SCIWORA) in children\", section on 'Radiologic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI has limited utility in the emergent setting because it is not available in many centers, requires prolonged investigation time for adequate evaluation and is not easily accessible to the critically ill child. CT myelography is an alternative to MRI in the patient for whom MRI is unavailable or contraindicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29088702\">",
"    <span class=\"h1\">",
"     RADIOLOGIC CERVICAL SPINE CLEARANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review has led to consensus cervical spine clearance guidelines for children with reliable (",
"    <a class=\"graphic graphic_algorithm graphicRef51439 \" href=\"mobipreview.htm?38/22/39264\">",
"     algorithm 2",
"    </a>",
"    ) and unreliable physical examinations (",
"    <a class=\"graphic graphic_algorithm graphicRef64196 \" href=\"mobipreview.htm?40/24/41358\">",
"     algorithm 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/7/32889/abstract/70\">",
"     70",
"    </a>",
"    ]. In addition, the reviewers felt that the literature strongly supports the following actions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is possible to clinically clear the pediatric c-spine. However, clinical clearance of children younger than two years of age based upon existing criteria should be performed with caution.",
"     </li>",
"     <li>",
"      Plain radiographs should be the initial radiologic study to evaluate for cervical spine injury in children. Computed tomography (CT) of the cervical spine should only be used as a follow up study for suspected bony injury on plain radiographs or when more diagnostic certainty is required based upon clinical factors such as mechanism of injury, associated injuries, or altered mental status. If CT is required, the study should ideally be limited to the vertebra of concern rather than imaging the entire c-spine.",
"     </li>",
"     <li>",
"      Magnetic resonance imaging should be performed in patients with an abnormal neurologic examination or when imaging of the spinal cord or other soft tissues of the spinal column is required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the consensus guidelines suggest CT of C1-C3 in all children less than or equal to eight years who are undergoing head CT, regardless of findings on plain radiographs and neurologic examination, some clinicians may choose to only perform CT in those children in whom an adequate odontoid view cannot be obtained and to only evaluate C1-C2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/0/15363?source=see_link\">",
"       \"Patient information: Neck fracture (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26106201\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cervical spine injury is rare in children, occurring in 1 to 2 percent of significant, severe blunt trauma cases. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children younger than eight years of age are more susceptible to injury of the upper cervical spine (C1 to C3) than older children and adults because of certain features of their anatomic development (",
"      <a class=\"graphic graphic_table graphicRef55343 \" href=\"mobipreview.htm?2/31/2555\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomic considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cervical spine injury must be suspected in all children who are severely injured or have high-risk injuries. Serious head injury and multiple-system trauma are commonly associated with spinal injuries and may distract the child from cervical pain or other important symptoms. In addition, cervical spine injury should be suspected in those children who have an underlying predisposition to such injuries. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic triad of symptoms includes local pain, muscle spasm, and decreased range of motion of the neck. Patients also may complain of early or immediate transient or persistent paresthesias or weakness. The distribution of transient symptoms is variable and ranges from involvement of the hands or feet to dramatic neurologic deficits, including quadriplegia. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Symptoms'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The principal elements of the physical examination of a child suspected of having a cervical spine injury are the vital signs, neck examination, and neurologic examination. The cervical collar may be removed for examination, with the maintenance of in line immobilization, if the patient has no symptoms suggestive of spinal cord injury (",
"      <a class=\"graphic graphic_algorithm graphicRef70732 \" href=\"mobipreview.htm?12/52/13134\">",
"       algorithm 1",
"      </a>",
"      ). The collar must be replaced and radiologic evaluation must ensue if any abnormalities suggestive of cervical spine injury are detected during the examination. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for radiologic evaluation of the cervical spine in children and adolescents are presented in the table (",
"      <a class=\"graphic graphic_table graphicRef79881 \" href=\"mobipreview.htm?9/11/9405\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/1\">",
"      Dietrich AM, Ginn-Pease ME, Bartkowski HM, King DR. Pediatric cervical spine fractures: predominantly subtle presentation. J Pediatr Surg 1991; 26:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/2\">",
"      Patel JC, Tepas JJ 3rd, Mollitt DL, Pieper P. Pediatric cervical spine injuries: defining the disease. J Pediatr Surg 2001; 36:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/3\">",
"      Chen LS, Blaw ME. Acute central cervical cord syndrome caused by minor trauma. J Pediatr 1986; 108:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/4\">",
"      Curran C, Dietrich AM, Bowman MJ, et al. Pediatric cervical-spine immobilization: achieving neutral position? J Trauma 1995; 39:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/5\">",
"      Baker C, Kadish H, Schunk JE. Evaluation of pediatric cervical spine injuries. Am J Emerg Med 1999; 17:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/6\">",
"      Hill SA, Miller CA, Kosnik EJ, Hunt WE. Pediatric neck injuries. A clinical study. J Neurosurg 1984; 60:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/7\">",
"      Fesmire FM, Luten RC. The pediatric cervical spine: developmental anatomy and clinical aspects. J Emerg Med 1989; 7:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/8\">",
"      Mohseni S, Talving P, Branco BC, et al. Effect of age on cervical spine injury in pediatric population: a National Trauma Data Bank review. J Pediatr Surg 2011; 46:1771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/9\">",
"      Orenstein JB, Klein BL, Gotschall CS, et al. Age and outcome in pediatric cervical spine injury: 11-year experience. Pediatr Emerg Care 1994; 10:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/10\">",
"      Cantor RM, Leaming JM. Evaluation and management of pediatric major trauma. Emerg Med Clin North Am 1998; 16:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/11\">",
"      Sun PP, Poffenbarger GJ, Durham S, Zimmerman RA. Spectrum of occipitoatlantoaxial injury in young children. J Neurosurg 2000; 93:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/12\">",
"      Brown RL, Brunn MA, Garcia VF. Cervical spine injuries in children: a review of 103 patients treated consecutively at a level 1 pediatric trauma center. J Pediatr Surg 2001; 36:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/13\">",
"      Jaffe DM, Binns H, Radkowski MA, et al. Developing a clinical algorithm for early management of cervical spine injury in child trauma victims. Ann Emerg Med 1987; 16:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/14\">",
"      Rachesky I, Boyce WT, Duncan B, et al. Clinical prediction of cervical spine injuries in children. Radiographic abnormalities. Am J Dis Child 1987; 141:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/15\">",
"      Leonard JC, Kuppermann N, Olsen C, et al. Factors associated with cervical spine injury in children after blunt trauma. Ann Emerg Med 2011; 58:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/16\">",
"      Parent S, Mac-Thiong JM, Roy-Beaudry M, et al. Spinal cord injury in the pediatric population: a systematic review of the literature. J Neurotrauma 2011; 28:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/17\">",
"      Hall DE, Boydston W. Pediatric neck injuries. Pediatr Rev 1999; 20:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/18\">",
"      Atlantoaxial instability in Down syndrome: subject review. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Pediatrics 1995; 96:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/19\">",
"      Herman MJ, Pizzutillo PD. Cervical spine disorders in children. Orthop Clin North Am 1999; 30:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/20\">",
"      Ruge JR, Sinson GP, McLone DG, Cerullo LJ. Pediatric spinal injury: the very young. J Neurosurg 1988; 68:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/21\">",
"      Peclet MH, Newman KD, Eichelberger MR, et al. Patterns of injury in children. J Pediatr Surg 1990; 25:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/22\">",
"      Bertolami CN, Kaban LB. Chin trauma: a clue to associated mandibular and cervical spine injury. Oral Surg Oral Med Oral Pathol 1982; 53:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/23\">",
"      Maroon JC. 'Burning hands' in football spinal cord injuries. JAMA 1977; 238:2049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/24\">",
"      Finch GD, Barnes MJ. Major cervical spine injuries in children and adolescents. J Pediatr Orthop 1998; 18:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/25\">",
"      Hoffman JR, Mower WR, Wolfson AB, et al. Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. National Emergency X-Radiography Utilization Study Group. N Engl J Med 2000; 343:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/26\">",
"      Viccellio P, Simon H, Pressman BD, et al. A prospective multicenter study of cervical spine injury in children. Pediatrics 2001; 108:E20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/27\">",
"      Pieretti-Vanmarcke R, Velmahos GC, Nance ML, et al. Clinical clearance of the cervical spine in blunt trauma patients younger than 3 years: a multi-center study of the american association for the surgery of trauma. J Trauma 2009; 67:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/28\">",
"      Anderson RC, Kan P, Vanaman M, et al. Utility of a cervical spine clearance protocol after trauma in children between 0 and 3 years of age. J Neurosurg Pediatr 2010; 5:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/29\">",
"      Jacobs LM, Schwartz R. Prospective analysis of acute cervical spine injury: a methodology to predict injury. Ann Emerg Med 1986; 15:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/30\">",
"      Apple JS, Kirks DR, Merten DF, Martinez S. Cervical spine fractures and dislocations in children. Pediatr Radiol 1987; 17:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/31\">",
"      Mower WR, Hoffman JR, Pollack CV Jr, et al. Use of plain radiography to screen for cervical spine injuries. Ann Emerg Med 2001; 38:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/32\">",
"      Sanchez JI, Paidas CN. Childhood trauma. Now and in the new millennium. Surg Clin North Am 1999; 79:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/33\">",
"      Ehara S, el-Khoury GY, Sato Y. Cervical spine injury in children: radiologic manifestations. AJR Am J Roentgenol 1988; 151:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/34\">",
"      Swischuk LE. Anterior displacement of C2 in children: physiologic or pathologic. Radiology 1977; 122:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/35\">",
"      Farley FA, Gebarki SS, Garton HL. Tectorial membrane injuries in children. J Spinal Disord Tech 2005; 18:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/36\">",
"      Harris MB, Duval MJ, Davis JA Jr, Bernini PM. Anatomical and roentgenographic features of atlantooccipital instability. J Spinal Disord 1993; 6:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/37\">",
"      Bonadio WA. Cervical spine trauma in children: Part I. General concepts, normal anatomy, radiographic evaluation. Am J Emerg Med 1993; 11:158.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Trauma. Spine and spinal cord trauma. In: Advanced Trauma Life Support for Doctors, American College of Surgeons, Chicago 1998. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/39\">",
"      Buhs C, Cullen M, Klein M, Farmer D. The pediatric trauma C-spine: is the 'odontoid' view necessary? J Pediatr Surg 2000; 35:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/40\">",
"      Swischuk LE, John SD, Hendrick EP. Is the open-mouth odontoid view necessary in children under 5 years? Pediatr Radiol 2000; 30:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/41\">",
"      Management of pediatric cervical spine and spinal cord injuries. Neurosurgery 2002; 50:S85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/42\">",
"      Pollack CV Jr, Hendey GW, Martin DR, et al. Use of flexion-extension radiographs of the cervical spine in blunt trauma. Ann Emerg Med 2001; 38:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/43\">",
"      Pennecot GF, Leonard P, Peyrot Des Gachons S, et al. Traumatic ligamentous instability of the cervical spine in children. J Pediatr Orthop 1984; 4:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/44\">",
"      Lewis LM, Docherty M, Ruoff BE, et al. Flexion-extension views in the evaluation of cervical-spine injuries. Ann Emerg Med 1991; 20:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/45\">",
"      Pang D, Pollack IF. Spinal cord injury without radiographic abnormality in children--the SCIWORA syndrome. J Trauma 1989; 29:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/46\">",
"      Freemyer B, Knopp R, Piche J, et al. Comparison of five-view and three-view cervical spine series in the evaluation of patients with cervical trauma. Ann Emerg Med 1989; 18:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/47\">",
"      Frohna WJ. Emergency department evaluation and treatment of the neck and cervical spine injuries. Emerg Med Clin North Am 1999; 17:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/48\">",
"      Ralston ME, Ecklund K, Emans JB, et al. Role of oblique radiographs in blunt pediatric cervical spine injury. Pediatr Emerg Care 2003; 19:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/49\">",
"      McCulloch PT, France J, Jones DL, et al. Helical computed tomography alone compared with plain radiographs with adjunct computed tomography to evaluate the cervical spine after high-energy trauma. J Bone Joint Surg Am 2005; 87:2388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/50\">",
"      Djang WT. Radiology of acute spinal trauma. Crit Care Clin 1987; 3:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/51\">",
"      Bachulis BL, Long WB, Hynes GD, Johnson MC. Clinical indications for cervical spine radiographs in the traumatized patient. Am J Surg 1987; 153:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/52\">",
"      Rybicki F, Nawfel RD, Judy PF, et al. Skin and thyroid dosimetry in cervical spine screening: two methods for evaluation and a comparison between a helical CT and radiographic trauma series. AJR Am J Roentgenol 2002; 179:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/53\">",
"      Adelgais KM, Grossman DC, Langer SG, Mann FA. Use of helical computed tomography for imaging the pediatric cervical spine. Acad Emerg Med 2004; 11:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/54\">",
"      Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics 2003; 112:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/55\">",
"      Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/56\">",
"      Crim JR, Moore K, Brodke D. Clearance of the cervical spine in multitrauma patients: the role of advanced imaging. Semin Ultrasound CT MR 2001; 22:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/57\">",
"      Jimenez RR, Deguzman MA, Shiran S, et al. CT versus plain radiographs for evaluation of c-spine injury in young children: do benefits outweigh risks? Pediatr Radiol 2008; 38:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/58\">",
"      Sanchez B, Waxman K, Jones T, et al. Cervical spine clearance in blunt trauma: evaluation of a computed tomography-based protocol. J Trauma 2005; 59:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/59\">",
"      Borock EC, Gabram SG, Jacobs LM, Murphy MA. A prospective analysis of a two-year experience using computed tomography as an adjunct for cervical spine clearance. J Trauma 1991; 31:1001.",
"     </a>",
"    </li>",
"    <li>",
"     Hockberger, RS, Kirshenbaum, KJ, Doris, PE. Spinal injuries. In: Emergency Medicine: Concepts and Clinical Practice, 4th, Rosen, P, et al (Eds), Mosby-Year Book, St. Louis 1998. p.462.",
"    </li>",
"    <li>",
"     American College of Radiology. Appropriateness criteria for imaging and treatment decisions. American College of Radiology, Reston, VA, 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/62\">",
"      Levitt MA, Flanders AE. Diagnostic capabilities of magnetic resonance imaging and computed tomography in acute cervical spinal column injury. Am J Emerg Med 1991; 9:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/63\">",
"      Selden NR, Quint DJ, Patel N, et al. Emergency magnetic resonance imaging of cervical spinal cord injuries: clinical correlation and prognosis. Neurosurgery 1999; 44:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/64\">",
"      Grabb PA, Pang D. Magnetic resonance imaging in the evaluation of spinal cord injury without radiographic abnormality in children. Neurosurgery 1994; 35:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/65\">",
"      Felsberg GJ, Tien RD, Osumi AK, Cardenas CA. Utility of MR imaging in pediatric spinal cord injury. Pediatr Radiol 1995; 25:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/66\">",
"      Matsumura A, Meguro K, Tsurushima H, et al. Magnetic resonance imaging of spinal cord injury without radiologic abnormality. Surg Neurol 1990; 33:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/67\">",
"      Flynn JM, Closkey RF, Mahboubi S, Dormans JP. Role of magnetic resonance imaging in the assessment of pediatric cervical spine injuries. J Pediatr Orthop 2002; 22:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/68\">",
"      Hyman RA, Gorey MT. Imaging strategies for MR of the spine. Radiol Clin North Am 1988; 26:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/69\">",
"      Fehlings MG, Rao SC, Tator CH, et al. The optimal radiologic method for assessing spinal canal compromise and cord compression in patients with cervical spinal cord injury. Part II: Results of a multicenter study. Spine (Phila Pa 1976) 1999; 24:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/7/32889/abstract/70\">",
"      Chung S, Mikrogianakis A, Wales PW, et al. Trauma association of Canada Pediatric Subcommittee National Pediatric Cervical Spine Evaluation Pathway: consensus guidelines. J Trauma 2011; 70:873.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6561 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-33503A3141-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32889=[""].join("\n");
var outline_f32_7_32889=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26106201\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cause of trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Mechanism of injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Vital signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Neck examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neurologic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RADIOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Lateral",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Anterior-posterior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Odontoid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Flexion-extension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Oblique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29088702\">",
"      RADIOLOGIC CERVICAL SPINE CLEARANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26106201\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6561\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6561|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?12/52/13134\" title=\"algorithm 1\">",
"      Cervical spine clinical clearance algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?38/22/39264\" title=\"algorithm 2\">",
"      Guideline for cervical spine clearance in the reliable child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?40/24/41358\" title=\"algorithm 3\">",
"      Guideline c-spine clearance unreliable child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6561|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/5/4191\" title=\"diagnostic image 1\">",
"      Morquio syndrome radiograph of C-spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/61/16337\" title=\"diagnostic image 2\">",
"      C5 compression fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/63/22513\" title=\"diagnostic image 3\">",
"      Hangmans fracture child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?40/39/41585\" title=\"diagnostic image 4\">",
"      Compression fracture C6 and C7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6561|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/26/16807\" title=\"figure 1\">",
"      Key sensory points",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/51/21297\" title=\"figure 2\">",
"      Cervical spine contour lines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/27/21944\" title=\"figure 3\">",
"      Posterior cervical line C1 C3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/2/35876\" title=\"figure 4\">",
"      Increased C1 to C2 spinous process distance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6561|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/8/26754\" title=\"picture 1\">",
"      Morquio syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6561|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/31/2555\" title=\"table 1\">",
"      Risk of spine injury in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/43/24253\" title=\"table 2\">",
"      Neurologic deficits in spinal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/11/9405\" title=\"table 3\">",
"      Radiologic evaluation of the C spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/57/6043\" title=\"table 4\">",
"      Pediatric anatomic variants C-spine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/6/7274?source=related_link\">",
"      Clinical features and diagnosis of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=related_link\">",
"      Detailed neurologic assessment of infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31274?source=related_link\">",
"      Evaluation and acute management of cervical spinal column injuries in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6615?source=related_link\">",
"      Jaw fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=related_link\">",
"      Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/0/15363?source=related_link\">",
"      Patient information: Neck fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/44/6854?source=related_link\">",
"      Pediatric cervical spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/52/12106?source=related_link\">",
"      Prevention of falls in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=related_link\">",
"      Spinal cord injury without radiographic abnormality (SCIWORA) in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_7_32890="NASH Light";
var content_f32_7_32890=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51497%7EGAST%2F59170%7EGAST%2F75188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51497%7EGAST%2F59170%7EGAST%2F75188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Nonalcoholic steatohepatitis on biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic changes in nonalcoholic steatohepatitis (NASH). Left panel: The hepatocyte in the center contains a large vacuole of fat and deeply staining eosinophilic strands of cytoplasmic hyalin. Numerous neutrophils and phagocytic cells containing golden brown pigmented material (bile components and cellular debris) are present in the sinusoids. Right panel: NASH with cirrhosis. Trichrome stain shows regenerating nodules with fat surrounded by fibrous tissue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nonalcoholic steatohepatitis liver biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Liver biopsy showing steatosis, hepatocyte balloon degeneration, mixed acute and chronic inflammation, and pericellular fibrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mallory-Denk bodies in alcoholic hepatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a liver biopsy in alcoholic hepatitis shows macrovesicular fat and Mallory-Denk bodies (arrows), which are eosinophilic accumulations of intracellular material. Similar changes can occur in nonalcoholic steatohepatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32890=[""].join("\n");
var outline_f32_7_32890=null;
var title_f32_7_32891="Gelatin content of vaccines";
var content_f32_7_32891=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F63833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F63833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gelatin content of vaccines (subject to change-check package inserts)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Vaccine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gelatin content in micrograms per dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Influenza (Fluzone, Sanofi Pasteur)",
"       </td>",
"       <td>",
"        250 micrograms per 0.5 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Influenza (Flumist, Medimmune vaccines)",
"       </td>",
"       <td>",
"        2000 micrograms per 0.2 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Measles, Mumps, Rubella (ATTENUVAX, MERUVAXII, MMRII, MMVAX, MUMPSVAX, Merck)",
"       </td>",
"       <td>",
"        14,500 micrograms per 0.5 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Measles, Mumps, Rubella, Varicella (ProQuad, Merck)",
"       </td>",
"       <td>",
"        11,000 micrograms per 0.5 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rabies (RabAvert, Chiron)",
"       </td>",
"       <td>",
"        12,000 micrograms per 1.0 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Varicella (VARIVAX, Oka/Merck)",
"       </td>",
"       <td>",
"        12,500 micrograms per 0.5 mL dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yellow Fever (YF-VAX, Sanofi Pasteur)",
"       </td>",
"       <td>",
"        7500 micrograms per 0.5 mL dose",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zoster (ZOSTAVAX, Oka/Merck)",
"       </td>",
"       <td>",
"        15,580 micrograms per 0.65 mL dose*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Package inserts.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Vaccine manufacturers, personal communication.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32891=[""].join("\n");
var outline_f32_7_32891=null;
var title_f32_7_32892="Causes reactive thrombocytosis";
var content_f32_7_32892=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F74148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F74148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of reactive thrombocytosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Nonmalignant hematologic conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute blood loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute hemolytic anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron deficiency anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment of vitamin B12 deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rebound effect after treatment of ITP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rebound effect after ethanol-induced thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Malignant conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metastatic cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rebound effect following use of myelosuppressive agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acute and chronic inflammatory conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatologic disorders, vasculitides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Functional and surgical asplenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        POEMS syndrome (osteosclerotic myeloma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tissue damage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thermal burns",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-surgical period, especially post-splenectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coronary artery bypass procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Allergic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Chronic renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrotic syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Reaction to medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vincristine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epinephrine, glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interleukin-1B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All-trans retinoic acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombopoietin, thrombopoietin mimetics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low molecular weight heparins (enoxaparin)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32892=[""].join("\n");
var outline_f32_7_32892=null;
var title_f32_7_32893="Antipsychotics for management of acute agitation";
var content_f32_7_32893=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F60846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F60846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antipsychotics for initial management of the acutely agitated adult patient with psychosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Formulation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initial dose (mg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency (hours)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Maximum initial dose per 24 hours (mg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time to peak plasma concentration (hours)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        First-generation agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Haloperidol",
"       </td>",
"       <td>",
"        Short-acting lactate injection",
"       </td>",
"       <td>",
"        IM, IV",
"       </td>",
"       <td>",
"        2-5",
"       </td>",
"       <td>",
"        0.5-2*",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.5-1",
"       </td>",
"       <td rowspan=\"2\">",
"        Sedation, hypotension and prolongation of QTc interval more pronounced with injection. &uarr; EPS risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral solution",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        0.5-5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\">",
"        Droperidol",
"       </td>",
"       <td>",
"        Injection (short-acting)",
"       </td>",
"       <td>",
"        IM, IV",
"       </td>",
"       <td>",
"        2.5-5",
"       </td>",
"       <td>",
"        2-4*",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        Rapid onset of 3-10 minutes advantageous in severely agitated violent patients. Dose related QTc prolongation and risk of cardiac arrhythmias. &uarr; EPS risk.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Fluphenazine",
"       </td>",
"       <td>",
"        Short-acting hydrochloride injection",
"       </td>",
"       <td>",
"        IM",
"       </td>",
"       <td>",
"        1.25",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        ND",
"       </td>",
"       <td rowspan=\"2\">",
"        1 mg short-acting IM injection is equivalent to ~2.5 mg oral. &uarr; EPS risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral solution",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        1-2.5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\">",
"        Chlorpromazine",
"       </td>",
"       <td>",
"        Injection (short-acting)",
"       </td>",
"       <td>",
"        IM, IV",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        1-4",
"       </td>",
"       <td>",
"        200",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        Hypotension, sedation and injection site pain are limiting side effects. Not a first-line agent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        Second-generation agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Aripiprazole",
"       </td>",
"       <td>",
"        Injection (short-acting)",
"       </td>",
"       <td>",
"        IM",
"       </td>",
"       <td>",
"        9.75",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td rowspan=\"2\">",
"        Less sedating. Minimal prolongation of QTc interval or orthostatic hypotension.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disintegrating tablet, oral solution",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        10-15",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        3-5",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Olanzapine",
"       </td>",
"       <td>",
"        Injection (short-acting)",
"       </td>",
"       <td>",
"        IM",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.25-0.75",
"       </td>",
"       <td rowspan=\"2\">",
"        Decreased clearance in female and/or non-smoking patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disintegrating tablet",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        0.5-2",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\">",
"        Risperidone",
"       </td>",
"       <td>",
"        Disintegrating tablet, oral solution",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        1-2",
"       </td>",
"       <td>",
"        0.5-2",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        Decreased clearance in renal and/or hepatic impairment.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"indent1\">",
"        Ziprasidone",
"       </td>",
"       <td>",
"        Short-acting mesylate injection",
"       </td>",
"       <td>",
"        IM",
"       </td>",
"       <td>",
"        10-20",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        0.5-1",
"       </td>",
"       <td>",
"        Dose related QTc prolongation and risk of cardiac arrhythmias.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Dose reduction necessary for older adults, debilitated patients and if used in combination with other sedation. See accompanying text for discussion of electrocardiograph and other monitoring for agents known to cause prolongation of the QTc interval.",
"    <div class=\"footnotes\">",
"     ND: no data; EPS: extrapyramidal symptoms.",
"     <br>",
"      * It may be necessary to repeat initial dose or fraction thereof after 15 to 20 minutes in patients with severe agitation until desired level of sedation attained.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32893=[""].join("\n");
var outline_f32_7_32893=null;
var title_f32_7_32894="Gram stain sputum 8C answer";
var content_f32_7_32894=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudomonas aeruginosa on MacConkey agar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Compare the mucoid (above) and non-mucoid (below) strains of Pseudomonas aeruginosa. Patients with cystic fibrosis often have mucoid P. aeruginosa in their sputum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32894=[""].join("\n");
var outline_f32_7_32894=null;
var title_f32_7_32895="UISS surveillance protoco";
var content_f32_7_32895=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F59623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F59623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    University of California-Los Angeles Integrated Staging System (UISS) surveillance protocols",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 532px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Based on early recurrence and frequency of pulmonary metastasis, we recommended chest CT scans; chest x-rays can be alternated with CT for HR after&nbsp;three years.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_7_32895=[""].join("\n");
var outline_f32_7_32895=null;
            